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Abstract
G-protein coupled receptors (GPCRs) form a large family of proteins and are very important drug
targets. They are membrane proteins, which makes computational prediction of their structure
challenging. Homology modeling is further complicated by low sequence similarly of the GPCR
superfamily.
In this dissertation, we analyze the conserved inter-helical contacts of recently solved crystal
structures, and we develop a unified sequence-structural alignment of the GPCR superfamily. We
use this method to align 817 human GPCRs, 399 of which are nonolfactory. This alignment can be
used to generate high quality homology models for the 817 GPCRs.
To refine the provided GPCR homology models we developed the Trihelix sampling method.
We use a multi-scale approach to simplify the problem by treating the transmembrane helices as
rigid bodies. In contrast to Monte Carlo structure prediction methods, the Trihelix method does a
complete local sampling using discretized coordinates for the transmembrane helices. We validate
the method on existing structures and apply it to predict the structure of the lactate receptor,
HCAR1. For this receptor, we also build extracellular loops by taking into account constraints from
three disulfide bonds. Docking of lactate and 3,5-dihydroxybenzoic acid shows likely involvement of
three Arg residues on different transmembrane helices in binding a single ligand molecule.
Protein structure prediction relies on accurate force fields. We next present an effort to improve
the quality of charge assignment for large atomic models. In particular, we introduce the formalism
of the polarizable charge equilibration scheme (PQEQ) and we describe its implementation in the
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Although living organisms seem to be infinitely complex, most of the diversity comes from the
complex interactions of the simple building blocks, such as twenty different amino acids. A protein
is a chain of amino acids, which fold into a compact structure due to the hydrophobic interaction
with surrounding water molecules. Most proteins adopt a unique conformation, which depend on the
order of amino acids in their sequence. The number of possible conformations grows exponentially
with the length of the amino acid chain. The exponential complexity is the source of biological
diversity, and at the same time is what makes it difficult to solve protein structures.
Proteins and molecules inside organisms can interact in many different ways. To organize multi-
cellular life, nature creates many different compartments, such as cells and organelles. Communicat-
ing information across membranes between the compartments is the means by which multicellular
organisms can function. G-Protein Coupled Receptors (GPCRs) are a large family of membrane
proteins, which sense diverse molecules outside of the cell and transfer the information inside the cell
where they regulate a number of signaling pathways. Since GPCRs are natural places to intercept
signaling pathways they are very important drug targets. Predicting atomistic models for GPCRs
would enable faster advances in drug discovery.
Structure prediction of GPCRs is a difficult problem because they are large proteins. Small
proteins with about 50 residues can be folded using molecular dynamics, which simulates the natural
dynamics of the protein [1]. Larger proteins with about 100 residues can often be solved with the
Monte Carlo method combined with fragment assembly or other sampling techniques [2]. The space
of the possible protein conformations scales exponentially with the size of the proteins. GPCRs are
large proteins with more than 300 residues, thus the current structure prediction techniques are too
slow given the presently available computational resources. To solve the structure of a large protein
the only possibility is to start with a similar protein, the homology model, and to try to refine it
with molecular dynamics or other sampling methods. The more we know about the type of proteins
in question, the better we can tailor the sampling method for structure prediction.
Because proteins are small — only a few nanometers in diameter — they represent a challenge
2to study. Many proteins have already been crystallized, thus their structure is already known to
within atomic resolution. In order to find a unique structure, these proteins are removed from their
native environment and crystallized at low temperature. In living organisms the proteins are often
dynamic structures acting as machines: sometimes they have a well-defined structure, sometimes
they fluctuate between multiple conformations, and sometimes they are completely disordered. In-
stead of a single snapshot, we can describe this dynamic structure as an ensemble of low lying
energy conformations. Each conformation belongs to some functional state, e.g. active and inactive.
When predicting new protein structures we pick the low energy model as the solution, and we also
consider several higher energy models as candidates for functionally important states of the protein.
Approaches based on energy function have been successful mainly for small globular proteins soluble
in water.
Structure prediction of membrane proteins is in its infancy compared to the structure prediction
of soluble proteins, because most of the membrane proteins are large as they need to span the 30
A˚ thick cell membrane. Also, there are significantly less known crystal structures of membrane
proteins, which means less training examples for the computational approaches. Yarov et al. [3]
developed a general membrane protein prediction method by generalizing the methods used for
soluble proteins, but it was not accurate enough for drug discovery. The recent assessment of
the GPCR structure prediction community, GPCRDock2013 [4], showed that approaches based on
homology models are currently the most successful [5]. In order to go beyond homology modeling,
we extend the ideas of the BiHelix method [6]. Our Trihelix method does complete local sampling
of the GPCR structures, while using discretized coordinates for the transmembrane helices. We use
physics tools to address the GPCR structure prediction. In particular, we use a multi-scale approach
to simplify the problem by treating the transmembrane helices as rigid bodies. Furthermore, we use
the mean field approximation in order to handle large number of conformations during the energy
evaluation stages.
The objective of this thesis is to computationally predict GPCR structures, which can then be
used in drug discovery. Since GPCRs are large proteins unsolvable by direct molecular dynamics,
we first study the known GPCR structures to identify features which help to model new proteins.
Based on this analysis we developed a sampling scheme to GPCR structure prediction. And finally
we apply this technique to predict the structure of the HCAR1 protein.
In Chapter 2 we analyze known GPCR structures in order to identify the features specific to
this protein superfamily. The analysis leads to a unified sequence-structural alignment of the GPCR
superfamily which can then be used to enable structure prediction of such large proteins. Another
result of this analysis is a list of residues which are critical for the receptor activation. Natural
variants for amino acids at these locations dramatically influence the activation mechanism, and so
these mutations can directly correspond to diseases.
3To model a protein with an unknown structure, we need to first map it to a protein with a
known structure. In Chapter 3 we construct an extension of this alignment to most other known
GPCR sequences. The result is a sequence alignment of transmembrane regions of 817 proteins,
and it is included in Appendix D. Using this alignment, an initial homology model for any GPCR
can be quickly prepared by mapping the corresponding residues to the most similar available crystal
structure.
The initial homology model has to be refined to describe the unique properties of the target pro-
tein. In Chapter 4, we describe the Trihelix sampling technique, which refines the initial homology
model by complete local sampling of the helical conformations of the transmembrane bundle. Practi-
cal methods are limited by the available computational resources, thus we decrease the exponentially
large space of conformations by sampling on a coarse grid and by taking mean field approximations
at several stages of the protocol. We test the Trihelix method on known crystal structures.
In Chapter 5, we apply the Trihelix method to predict the structure of the HCAR1 protein,
which has recently been connected to the regulation of pancreatic cancer. To complete the model,
we build the extracellular loops using a new approach specific to GPCRs, which uses constraints
from known disulfide bonds. Finally, we dock lactate and and 3,5-dihydroxybenzoic acid molecules
to the protein model. The binding sites show a single ligand molecule interacting with three Arg
residues, each on a different transmembrane helix, in agreement with available mutation data.
Both the structure prediction and ligand binding calculations rely on evaluation of energy of the
models. An important component of the underlying calculations is the determination of the atomic
charges. In the final Chapter 6, we describe an extension of the QEQ charge equilibration method,
which includes polarization. We derive the relevant formulas and describe the implementation in the
Lammps molecular dynamics code. Optimization of atomic parameters for this method is presented
in [7]. This work is part of ongoing efforts to improve the energy models for molecular simulations.
4Chapter 2
GPCR Fold and Structure Based
Alignment
2.1 Signal Messengers
Signal transduction coordinates all life processes in multicellular organisms. All signals have to
cross biological membranes, and therefore the membranes are a natural place to intercept biological
pathways. G-Protein Coupled Receptors (GPCRs) are a large superfamily of membrane proteins
facilitating information transfer across the cellular membrane.
In humans, GPCRs are sensitive to neurotransmitters, hormones, metabolites, and odors among
other molecules [8]; rhodopsin is even sensitive to light thanks to the small molecule retinal. This
means that proteins from this superfamily control a very diverse set of interactions in the human
body. Different GPCRs regulate neural signaling in the brain, control blood pressure, influence
metabolism, and are responsible for sensory function of vision, taste, and smell. Out of about
20,000 human proteins [9], there are about 800 human GPCRs [10], half of which are olfactory
receptors. This leaves almost 400 GPCRs which can serve as drug targets. Currently, about 30-50%
of all drugs and 20% of recently FDA approved drugs act via GPCRs [11], which makes the structure
prediction of these protein very important for drug discovery.
There are multiple mechanisms of signal transduction via GPCRs. The best described pathway is
the β2 adrenoreceptor activation and Gs protein binding [12] (Fig. 2.1). First, an agonist binds to the
extracellular part of the β2 adrenoreceptor. While the binding causes relatively small conformational
changes in the ligand pocket, it induces large conformational changes of the transmembrane helices.
The movement of the helices then enables binding of the Gs heterotrimer (with subunits α, β,
and γ) on the intracellular side. After Gs binding, the α subunit releases GDP. Then, GTP can
bind to the α subunit, resulting in the separation of the α and βγ subunits from the GPCR. After
that, both subunits regulate their respective pathways until GTP is hydrolyzed to GDP and the Gs
heterotrimer can be reassembled.
5Figure 2.1: Typical mechanism of signal transduction by a GPCR. Source: [12].
This description of the activation mechanism is a result of a decade long effort on crystallization
of the active state of a GPCR receptor. Membrane proteins are very difficult to crystalize compared
to soluble proteins because folded proteins need to be removed from the membrane environment.
Crystallization of GPCRs is even more difficult because the GPCR is not a rigid structure but rather
a flexible and dynamic one. The degree of flexibility has been observed with fluorescence studies
[13, 14] and long molecular dynamics (MD) simulations (up to 30 µs [15]). Therefore, the structure
determination of a GPCR should not look for a single structure but rather the dynamic ensemble
of structures low in the energy landscape.
2.2 Transmembrane Helices as Basis For Structure Predic-
tion
The cellular membrane divides a GPCR protein into 3 regions: extracellular, membrane, and in-
tracellular. The N-terminus and three extracellular loops (EC1, EC2, EC3) lie outside of the cell.
Seven transmembrane (TM) helices (TM1-7) span the membrane. And inside the cell, there are three
intracellular loops (IC1, IC2, IC3) together with the C-terminus, which is typically a shorter helix 8
(see Figure 2.2). The intracellular and extracellular loops have different lengths and admit different
conformations among the known GPCR crystal structures. However, the fold of the transmembrane
helices is very well conserved even for proteins with very small sequence similarity.
We use this common GPCR fold as a basis for structure prediction method for all GPCRs.
GPCRs are large proteins with more than 300 residues, and thus difficult to model with the usual
ab-initio protein modeling methods [17, 3]. Since the common GPCR fold is formed by alpha-helices,
to first approximation, we can think of these as rigid bodies. In order to predict the structure of a
novel GPCR we start from the most similar known structure, template, and then refine the structures
with the necessary rigid body moves of the TM helices.
6Figure 2.2: β2 adrenoreceptor in complex with Gs protein (with subunits α, β, and γ). The mem-
brane divides the receptor into the extracellular part (N-terminus, EC1-3), transmembrane helices,
and the intracellular part (IC1-3, C-terminus). Image source: [16], structure: [12].
7Figure 2.3: Phylogenetic tree of 342 human GPCRs by Fredrikson et al [18]. Red flags denote crystal
structures solved prior to May 2014. The denoted groups can be assigned to the GPCR classes as
follows: class A (rhodopsin-like receptors), class B (secretin and adhesion family), class C (glutamate
receptors), and class F (frizzled and bitter taste receptors). Source: GPCR Network [10], a large
collaboration trying to experimentally determine structure of many GPCRs.
2.3 Class A Alignment
Before we can model the TM bundle from a suitable template, we need to find the optimal sequence
alignment. This turns out not to be an easy task for GPCRs because they are a very diverse class of
receptors. There are many ways to classify the GPCR family, e.g., the International Union of Basic
and Clinical Pharmacology classifies the receptors by known ligands [8], whereas sequence based
classifications are used in [19, 20, 18, 21].
First, we use the usual classification of the GPCR superfamily into the classes A-F. In Chapter
3 we suggest a new classification based on TM similarity that is suitable for structure predic-
tion. Fredrikson et al [18] performed detailed phylogenetic analysis further dividing classes A-F
into branches: class A (rhodopsin-like receptors), class B (secretin and adhesion family), class C
(glutamate receptors), and class F (frizzled and bitter taste receptors). Figure 2.3 shows the re-
sulting phylogenetic tree of 342 nonolfactory human GPCR proteins. Classes D, E are part of the
classification that includes other species, but contain no human proteins.
Sequence alignment is typically possible within each GPCR class separately, not because the
whole sequences are similar enough, but because of several conserved motifs. In particular, the class
8TM .46 .47 .48 .49 .50 .51 .52 .53
1 G N x x V
2 L x x x D
3 E/D R Y
4 W
5 F x x P
6 C W x P F F
7 N P x x Y
Table 2.1: Class A conserved motifs for each TM. x denotes a non-conserved residue. The numbers
correspond to the Ballesteros-Weinstein numbering scheme [22], in which n.50 is the most conserved
residue in TM n.
A proteins have highly conserved residues at specific positions, which are displayed in Table 2.1.
These highly conserved residues define the n.50 residue Ballesteros-Weinstein numbering scheme
[22] and are often involved in inter-helical hydrogen bonding or correspond to a proline kink in the
alpha helix.
Figure 2.4 shows the structural alignment of the class A structures corresponding to the class
A sequence alignment. All the structures are in the same fold, as the backbone root mean square








where the sum runs over corresponding pairs of atoms at positions r1i and r2i. For comparing similar
folds we include only backbone atoms from each amino acid: N, Cα, C, O.
Furthermore, the correspondence of the residues in this alignment is very good, since the corre-
sponding residues overlap, as can be seen in Figure 2.5. The figure shows the residues involved in
hydrogen bonding networks, which are most conserved in class A. Thus, within class A we see the
structural biology paradigm at work:
Sequence ∼ Structure ∼ Function
Within class A, the sequence identity between the corresponding transmembrane regions is 15-40%
(Figure B.3). However, the sequence identity between class A and GPCR proteins from other classes
is so low, typically 5-15%, that one cannot simply align the sequences between GPCRs from different
classes. At present, there are 5 non-class A GPCR structures available. When these structures are
properly aligned to class A, it is clear that they are in the same fold as class A GPCRs (see Figure 2.6),
thus leading to a disagreement with the structural biology paradigm within the GPCR superfamily:
Sequence  Structure ∼ Function
9(a) View at TM 1, 2, 3, 4 (b) View at TM 5, 6, 7, 1
Figure 2.4: 20 different class A structures aligned to β2. The helices overlap each other very well,
showing how well-defined the class A TM fold is. Each TM has a different color. Loops are omitted
since they do not share the same fold. Detailed view is shown in Fig. 2.5. Rendered using PyMOL
[23].
(a) W4.50 ↔ S/N/T2.45 ↔ S/N/T3.42 (b) N1.50 ↔ D2.50 ↔ N7.49 (water-mediated)
Figure 2.5: Detailed view into Fig. 2.4 showing conserved motifs in class A GPCRs. Even though
20 different crystal structures are shown, the conserved residues have a very similar position.
10
(a) View at TM 1, 2, 3, 4 (b) View at TM 5, 6, 7, 1
Figure 2.6: All available structures aligned to β2. 20 different class A structures are colored green.
CRF1 is cyan, GLR is blue (both class B). MGLU1 is orange, MGLU5 is red (both class C). SMO is
magenta (class F). The corresponding helices overlap each other quite well, showing how well defined
the general GPCR TM fold is.
In the next section, we construct the optimal sequence alignment, which corresponds to the Figure
2.6.
One way to align two GPCR structures with small sequence identity is to use a fully structural
alignment. Structural alignment typically works iteratively, removing from the alignment those
atoms which were too far in the previous rounds. This works relatively well, but the exact sequence
pairing is not uniquely defined and depends on the cutoff parameter. In many cases it leaves an
ambiguity of ±4 residues (1 helical turn).
In order to remove this ambiguity and to see which alignment would minimize the RMSD of the
full TM bundle, we start from the approximate structural alignment, and try all nearby sequence
alignments (±1 helical turn on each helix). But minimizing only RMSD does not necessarily lead
to an optimal alignment. For several cases in class A, we find TM alignments which have slightly
lower RMSD than the alignment conserving the Ballesteros-Weinstein residues. The reason for this
is that the extracellular ends of the helices sometimes have significantly different tilt, so the most
tilted helix can dominate the RMSD measure. To avoid these issues with the RMSD measure, we
instead analyze conserved inter-helical contacts. In the following section, we obtain the alignment,
which leads to the structural alignment of all available GPCR proteins on Figure 2.6.
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Class Ligand Protein Name Short Gene PDB Id PDB Id Uniprot Ref.
Inactive Active
Aα opsin bovine rhodopsin RHO RHO 1GZM.A 3PQR.A P08100 [25, 26]
Aα aminergic turkey β1 adrenergic receptor β1AR ADRB1 2VT4.B P08588 [27]
Aα aminergic human β2 adrenergic receptor β2AR ADRB2 2RH1.A 3SN6.R P07550 [28, 12]
Aα aminergic human dopamine D3 receptor D3 DRD3 3PBL.A P35462 [29]
Aα aminergic human histamine H1 receptor H1 HRH1 3RZE.A P35367 [30]
Aα aminergic human muscarinic acetylcholine receptor M2 M2 CHRM2 3UON.A 4MQS.A P08172 [31, 32]
Aα aminergic rat muscarinic acetylcholine receptor M3 M3 CHRM3 4DAJ.A P20309 [33]
Aα aminergic human serotonin receptor 1B 5HT1B HTR1B 4IAR.A P28222 [34]
Aα aminergic human serotonin receptor 2B 5HT2B HTR2B 4NC3.A P41595 [35]
Aα nucleoside human adenosine receptor A2a A2A ADORA2A 3EML.A 3QAK.A P29274 [36, 37]
Aα lipid human sphingosine 1-phosphate receptor 1 S1P1 S1PR1 3V2Y.A P21453 [38]
Aβ peptide rat neurotensin receptor type 1 NTS1 NTSR1 4GRV.A P30989 [39]
Aγ peptide human C-X-C chemokine receptor 4 CXCR4 CXCR4 3ODU.A P61073 [40]
Aγ peptide human C-C chemokine receptor 5 CCR5 CCR5 4MBS.A P51681 [41]
Aγ peptide human κ-opioid receptor κOR OPRK1 4DJH.A P41145 [42]
Aγ peptide mouse µ-opioid receptor µOR OPRM1 4DKL.A P35372 [43]
Aγ peptide human nociceptin/orphanin FQ opioid receptor NOP OPRL1 4EA3.A P41146 [44]
Aγ peptide mouse δ-opioid receptor δOR OPRD1 4EJ4.A P41143 [45]
Aδ peptide human proteinase-activated receptor 1 PAR1 F2R 3VW7.A P25116 [46]
Aδ nucleoside human P2Y purinoreceptor 12 P2Y12 P2RY12 4NTJ.A Q9H244 [47]
B peptide human corticotropin-releasing factor receptor 1 CRF1 CRHR1 4K5Y.B P34998 [48]
B peptide human glucagon receptor GLR GCGR 4L6R.A P47871 [49]
C peptide human metabotropic glutamate receptor 1 MGLU1 GRM1 4OR2.A Q13255 [50]
C peptide human metabotropic glutamate receptor 5 MGLU5 GRM5 4OO9.A P41594 [51]
Frizzled peptide human smoothened homolog SMO SMO 4N4W.A Q99835 [52, 53]
Table 2.2: List of GPCRs with available crystal structure. When multiple structures were available,
then the one with the highest resolution or the one with least deformed TM helices is listed.
2.4 Alignment Based on Common Contacts
In class A, the analysis of inter-helical interactions typically focuses on hydrogen bonds because
many of the hydrogen bonding residues are highly conserved. However, the sequence is not conserved
between different classes, and therefore we look at conserved contacts instead. We use the definition
of a inter-helical contact as in [24]: any two heavy atoms from different TMs that are closer than
the sum of their van der Waals radii plus 0.6 A˚.
All known crystal structures are listed in Table 2.2. Many of the transmembrane helices contain
bends, and sometimes the termination of the helices is not well defined. We define the extent of each
transmembrane helix as the residues positioned in the membrane (as placed by the Orientations of
Proteins in Membranes (OPM) database [16]) extended until the end of the alpha helix by the DSSP
secondary structure determination [54]. The helices were manually inspected and only a few manual
corrections were needed. The final TM lengths are displayed in Table B.1.
Once the TM regions are defined, we analyze the number of inter-helical contacts of all known
structures (listed in Table 2.2). Each structure has about 200 contacts (see Table B.1). For class A,
the alignment preserving Ballesteros-Weinstein (BW) numbering maximizes the number of common
contacts between any two structures. For Classes B, C, and F the BW numbering is not defined,
because the sequence is not conserved. Starting with an approximate initial structural alignment,
we try all possible adjustments to BW 50 residues on each helix and count the number of contacts
common with any of the class A structures.
Table 2.3 shows the best alignments. Class B (CRF1, GLR) alignment agrees with the suggested
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TM1 TM2 TM3 TM4 TM5 TM6 TM7 Common contacts
CRF1 L134 F162 L213 W236 V279 L329 S360 2212
L134 F162 L213 W236 V279 I325 A363 2084
L134 F162 L213 W236 V279 I325 S360 2081
GLR L156 F184 L249 W272 A314 V364 A397 1972
L156 F184 L249 G273 A314 V364 A397 1913
L156 F184 L249 M276 A314 V364 A397 1876
MGLU1 T607 I638 I682 I714 L763 A800 L827 2017
T607 I638 I682 S711 L763 A800 L827 2012
T607 I638 I682 S711 C767 A800 L827 1873
MGLU5 T594 I625 A669 F698 L750 A787 L814 1974
T594 I625 A669 I701 L750 A787 L814 1954
T594 I625 A669 F698 L750 I784 L814 1820
SMO T245 F274 W339 W365 V411 I465 S533 2358
T245 F274 W339 W365 V411 C469 G529 2311
T245 F274 W339 W365 V411 C469 S533 2283
...
T245 F274 W339 W365 V411 S468 I530 1827
Table 2.3: This table shows the selection process for assigning BW .50 residues to non class A
proteins. Shifting BW .50 residue on each helix renumbers the relative BW numbers, effectively
changing the labels of contacts observed in these proteins. Subsequently, the number of common
contacts each structure shares with the class A structures is different for different BW residue
assignments. The rightmost column shows the cumulative number of contact occurrences among
the 24 class A structures. The BW assignment with the highest number of contacts is selected
(except for MGLU5). The selected alignment is in bold.
alignment in [49], which was obtained by an iterative structural alignment. Similarly, we chose class
C (MGLU1, MGLU5) alignment, which agrees with the suggested alignment in [50]. For MGLU5,
only the second highest scoring alignment was chosen, so that the alignment is consistent with the
MGLU1. This choice was checked manually and the corresponding residues are in a more similar
position in the selected alignment.
For the SMO receptor our procedure obtains different sequence alignment than the iterative
structural alignment [52]. The proposed alignment is shown on the last line on Table 2.3, and it
differs from reference [52] in helix 6 and 7. Helix 7 of the SMO receptor does not have any proline
residue, and so it is missing the kink that is typical for class A. There are many inter-helical contacts
in the extracellular part of the TM7, and so the chosen alignment gives a good spatial correspondence
for the larger part of helix 7.
This alignment was used to overlay the structures on Fig. 2.6. The RMSD of the TM bundle
alignment between classes is about 2.5-3.5A, from which we reach the surprising conclusion that the
class B, C and, F proteins share the same fold as class A. Thus considering all GPCRs, we have an
example of proteins with similar structure and function, but dissimilar sequence:
Sequence  Structure ∼ Function
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Figure 2.7: β2 crystal structure in two side views. Inter-helical contacts conserved in class A are
represented as dotted lines in magenta. The residues forming them are displayed using stick repre-
sentation. The detailed list of the contacts is in Fig. 2.8.
It may be possible to gain new insights into the class A fold by comparing it to the other classes.
Chapter 3 uses this alignment of the known crystal structures and generalizes it to the alignment
for most of the GPCR sequences by anchoring each subfamily to the known alignment.
2.5 Conserved Contacts
Venkatakrishnan et al. [24] pointed out that, besides several hydrogen bonds, a large number of inter-
helical contacts are conserved for most structures in class A. Considering any inter-helical contacts,
and not just hydrogen bonds, is better for comparing structures across the GPCR classes, since the
chemical nature of the contacts does not have to be conserved. For a diverse set of proteins, the
residues can mutate from polar to hydrophobic while the contact of the nearby residues is preserved.
In the previous section we used common contacts as a way to compare structures across the GPCR
classes. In this section we extend the comparison to find common contacts that possibly define or
constrain the GPCR fold. This analysis provides additional insights that are useful for modeling
large proteins.
The inter-helical contacts, which are present in almost all studied class A structures, are displayed
in Fig. 2.7 and listed in Figure 2.8. This list is very similar to the contacts found by [24], but there









TM2-TM3: 2.42-3.45, 2.42-3.46, 2.45-3.42, 2.46-3.39,
2.46-3.42, 2.53-3.35
TM3-TM4: 3.34-4.53, 3.34-4.57, 3.37-4.53, 3.38-4.50,
3.38-4.53, 3.41-4.49
TM3-TM5: 3.47-5.57, 3.51-5.57, 3.51-5.60, 3.51-5.61
TM3-TM6: 3.36-6.48, 3.40-6.44, 3.43-6.44
TM2-TM4: 2.45-4.46
TM5-TM6: 5.47-6.52
TM6-TM7: 6.47-7.41, 6.47-7.42, 6.47-7.45, 6.48-7.42,
6.51-7.38, 6.51-7.39
TM2-TM7: 2.43-7.53, 2.50-7.46
TM1-TM2: 1.43-2.54, 1.43-2.58, 1.46-2.54, 1.50-2.47,
1.50-2.50, 1.50-2.51, 1.53-2.47, 1.54-2.47,
1.57-2.44
TM1-TM7: 1.46-7.47, 1.50-7.50
Figure 2.8: Diagram of inter-helical contacts present in at least 23 out of 24 studied class A structures.
The contacts common to all classes are in blue, and contacts present only in class A in orange.
compare the list of chemically unspecific contacts to the conserved hydrogen bonds. Within class
A, one often focuses on two conserved networks of hydrogen bonds, which were shown on Fig 2.5:
W4.50 ↔ S/N/T2.45 ↔ S/N/T3.42 and N1.50 ↔ D2.50 ↔ N7.49.
Fig. 2.8 shows that the network 4-2-3 is well conserved across classes. In particular, the contact
2.45-3.42 is present in all classes, and there are many conserved contacts in its immediate vicinity,
such as 2.42-3.45, 2.42-3.46, and 2.46-3.42. The contact between TM 3 and 4 is also well conserved,
as the highly conserved bulky residue W4.50 leans on A3.38.
The network 1-2-7 also has many conserved contacts, including N1.50-D2.50, but interactions
with N7.49 are not conserved. Even In class A, N7.49 interacts with the other residues of this
hydrogen bonding network indirectly through a water molecule. Still, the side chain packing in the
regions where the helices are close together is important for structural stability.
Any mutations to the conserved contacts can cause structural stability issues for the protein.
Thus, naturally occurring mutations of the residues involved in the conserved contacts could be
direct causes of diseases. In the next section we discuss several diseases and disorders caused by
naturally occurring single nucleotide polymorphisms (SNP). The exact position of each SNP is
important since it determines whether the SNP causes some structural defects or whether it is likely
to be benign. The positions of many SNPs are known from genetic studies, and by using the global
GPCR alignment, which is derived in the next chapter, we can get the BW numbering of each
SNP. The BW numbers of each SNP can then be compared against the list of conserved contacts to
estimate their importance.
We cannot determine with confidence the conserved contacts in classes B, C, and F yet, because
there are at most two structures in each of these classes. Nevertheless, we start the analysis with the
available structures, so that we at least reduce the number of residues that can be more structurally
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important. There are two structures available in classes B, C and only one in class F. Figures 2.9a,
2.9b, and 2.9c show the inter-helical contacts found in classes B, C, and F. The lists show interactions
which should be considered first when one studies the structure or function of these proteins.
Even though the sequence similarity between the classes is low, there are structural similarities.
Especially important are the similarities on the intracellular side of the GPCRs, since the same G-
proteins bind to all GPCR classes. Let us now compare class A to the other classes. The blue color
in Fig. 2.8 denotes the contacts common to all classes, and orange denotes contacts specific to class
A. Only one contact, 6.51-7.39, is present in all of class A structures (active and inactive), but not
in the structures of the other classes. Furthermore, the interactions of TMs 1-5 are more conserved
across all classes, but the TM 6 and 7 contacts are very class A specific. It is possible that during
the GPCR assembly the helices 1-5 form some intermediate partially folded state before helices 6
and 7 are fully present in the membrane. This might be the reason why the contacts between helices
1-5 are more similar across the classes. Another possibility is that the motion of TM6, which is
critical for activation, is different for classes B, C, and F.
To summarize, in this section we identified mutations which likely cause structural changes in
proteins. We next study mutations that cause functional problems.
2.6 Inter-helical Contacts Involved in Activation
In this section we show that the class A activation mechanism relies critically on a small number of
residues. If any of these residues is mutated, the free energy balance between the active and inactive
states is modified, and the receptor is likely to become either constitutively active or inactive, which
is often the cause of a disease. Comparing the common contacts among different proteins, as we
did in the previous section, is not straightforward because many of the sequence differences are
random. Focusing on the difference between active and inactive structures of the same protein
makes the significance of the individual residues much clearer. There are 3 active-inactive structure
pairs available: RHO, β2AR, and M2. The active structure of A2A is only partially active, and for
NTS1act the inactive structure is not available.
For rhodopsin, which is the most studied, the main signature of activation is the breaking of the
salt-bridge R3.50↔E6.30 and the forming of the salt-bridge K5.66↔E6.30. Instead of keeping track
of hydrogen bonds only, the analysis of contacts allows us to study more general changes during
the activation. Figure 2.10 shows the common changes in contacts among all the active-inactive
structure pairs.
Most of the changes occur for TM 6, since the intracellular end of helix 6 undergoes the largest
movement upon activation. However, TM 7 also shows a large number of systematic changes, as









(a) Class B: CRF1, GLR
TM2-TM3: 2.63-3.25
TM6-TM7: 6.47-7.38








(b) Class C: MGLU1, MGLU2
TM2-TM3: 2.48-3.38, 2.52-3.38, 2.59-3.27
TM3-TM4: 3.33-4.53, 3.37-4.50, 3.41-4.46, 3.44-4.49,
3.45-4.42
TM3-TM5: 3.33-5.47, 3.37-5.50
TM3-TM6: 3.40-6.41, 3.43-6.37, 3.46-6.33
TM3-TM7: 3.32-7.38, 3.40-7.45
TM2-TM4: 2.42-4.43
TM4-TM5: 4.49-5.46, 4.53-5.43, 4.53-5.47
TM5-TM6: 5.37-6.56, 5.41-6.56, 5.44-6.48, 5.44-6.51,
5.48-6.48, 5.59-6.42
TM6-TM7: 6.55-7.34, 6.55-7.37
TM2-TM7: 2.46-7.54, 2.50-7.54, 2.54-7.43, 2.54-7.47,
2.60-7.38









(c) Class F: SMO
TM2-TM3: 2.50-3.36, 2.57-3.36
TM3-TM5: 3.43-5.50, 3.50-5.62
TM3-TM6: 3.43-6.45, 3.50-6.38, 3.50-6.42, 3.53-6.34
TM3-TM7: 3.46-7.49
TM5-TM6: 5.44-6.59, 5.47-6.51, 5.50-6.48, 5.58-6.45,
5.62-6.42
TM6-TM7: 6.33-7.52, 6.36-7.51, 6.40-7.51, 6.47-7.40,
6.50-7.40
TM2-TM7: 2.40-7.52, 2.50-7.42, 2.57-7.42
TM1-TM2: 1.36-2.60
TM1-TM7: 1.31-7.32, 1.35-7.32, 1.35-7.35, 1.38-7.39,
1.52-7.53, 1.56-7.53, 1.57-7.52
Figure 2.9: Diagram of interhelical contacts present in classes B, C, and F. The width of the line
connecting two TMs is proportional to the number of contacts present in all structures from the































TM3-TM6: 3.43-6.40, 3.43-6.41, 3.46-6.37, 3.50-6.37 3.50-6.40
TM3-TM7: 3.43-7.49, 3.43-7.53, 3.46-7.53




Figure 2.10: Diagram of interhelical contacts changed upon activation. Width of the green lines is
proportional to the number of contacts common to all six structures (RHO, β2AR, M2, and their
active structures). Blue shows the contacts present only in inactive structures, but in no inactive
structures; and red shows the opposite. The upper diagrams show contacts in the extracellular
half of the membrane. We see that there is no systematic change common to the class A receptors
in the conformation of the extracellular half of the TMs. This is not obvious, because there are
conformational changes accompanying ligand binding. All the systematic changes, which enable
G protein binding, occur in the intracellular half of the TMs. The list only contains 16 different
residues, but it has 15 different contacts. Thus many of the residues switch partners upon activation.
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3.46 occur in the list of conserved contacts in both active and inactive structures, therefore the
conformational changes around these residues seem to be very important for the conformational
changes during activation.
It has been experimentally shown that single amino acid mutations can have a dramatic effect
on GPCR activity. For example, the mutation T3.46A makes the receptor CB1 inactive, while the
mutations T3.46I and L3.43A make it constitutively active [55, 56]. These mutations are introduced
by experimentalists, but the exact list of contacts on Figure 2.10 is useful for explaining certain
natural variants as well. Below we provide several examples. We scanned the Uniprot database [57]
for naturally occurring mutations and converted the residue numbering to the BW scheme using our
alignment.
For example, the natural variants R3.50C and R3.50L cause the vasopressin V2 receptor to
be constitutively active. This causes ‘nephrogenic syndrome of inappropriate antidiuresis’, which
presents itself as an inability to excrete a free water load, resulting in low sodium levels [58]. The
mutations of R3.50 clearly interfere with arginines’s ability to form hydrogen bonds, and so they
disrupt the activation mechanism.
Similarly the natural variant H2.43R in Parathyroid hormone receptor causes its constitutive
activity. This mutation of class B receptor causes ‘Jansen metaphyseal chondrodysplasia’, which is
characterized by short-limbed dwarfism [59]. Since the same G proteins couple to different GPCR
classes, we can expect the same or similar structural signatures of activation in class B as in class
A.
For both of these examples the mutations were shown to cause constitutive activity. However,
the Uniprot database also shows many natural mutations, for which the effect is unknown.
For example, we predict that the mutation M3.43T of the G-protein coupled receptor 56 will
influence its activation, because the residue 3.43 has to switch contact residues during activation.
This adhesion GPCR is involved in cell adhesion as well as in cell to cell interactions, and regulates the
migration of neural precursor cells; thus the mutation likely has serious consequences. No databases
of single nucleotide polymorphisms contain any information about this mutation (we checked the
TinyGRAP [60] and NAVA [61] databases), therefore this is a true prediction.
Another example is the T6.36P mutation of the D(1B) dopamine receptor. This is a class A
receptor and it influences the activity of adenylyl cyclase. Again, we predict that the T6.36P
mutation makes the receptor either constitutively active or fully inactive.
Finally, let us consider natural variants of the HCAR1 receptor, whose structure we study in the
next chapter. The receptor has four known naturally occurring mutations [62]:
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H43Q no effect IC1
A110V reduced activity 3.47, close to 3.46
S172L reduced activity EC2
D253H reduced activity EC3
In this case, we can attribute the 3.47V mutation to influencing the activation mechanism due
to indirect interaction with the 3.46 residue. The mutations S172L and D253H likely influence
the sensitivity to the endogenous ligand of HCAR1, lactate, by changing the loop structure of the
receptor.
To summarize, in this section we identified specific residues which are critical for GPCR ac-
tivation. We illustrated the importance of these residues by finding diseases that are caused by
mutations on these residues. The list of residues directly involved in activation only contains 16
residues, which is only about 5% of the residues in the transmembrane domain.
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Chapter 3
Extension of Alignment to All
GPCRs
3.1 Low Sequence Similarity Between Classes
In Section 2.4 we described how to construct a sequence alignment for all the known GPCR crystal
structures. We had to use structural information to find the relation between the different classes, as
the sequence similarity across the classes is very low. In this section we study in detail the differences
between the structures.
Since most of the proteins are in class A, we projected the Ballesteros-Weinstein numbering [22]
to the other classes. In this scheme, the most conserved residue for each TM is denoted n.50 (n
= 1 to 7 denotes the TM). We use this numbering even for classes B, C, and F, in which different
residues might be most conserved on some of the TMs. For example, class B Wootten numbering
[63] labels n.50 residues which are most conserved within this class only.
Figure 3.1 shows the alignment of the TM3 regions for all the studied crystal structures. We
can see that the DRY motif at positions 3.49-3.51 is highly conserved within class A (in all but the
last 5 sequences), and even when there are mutations only similar amino acids occur: ERY, DRF.
In classes B, C, and F the DRY motif is not conserved at all.
Proline residues often cause a helix kink, so they are structurally important for deciding which
structure should be used as template for modeling a new protein. In Figure 3.1, prolines are high-
lighted in red. Only MGLU5 has a proline in a central region of TM3, but in this case, the shape of
TM3 is very similar to MGLU1, which does have the corresponding proline.
The consensus sequence for TM3 mostly agrees with class A residues, because most of the crystal
structures are from the class A. Interestingly the most conserved residue across all classes is Cys3.25,
which forms a disulfide bond to the extracellular loop EC2. This bond is important for the stability
of the protein, and if one of the cysteine residues forming this bond is mutated, the protein does not
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F C A A C H G C L F I A C F V L V L T Q S S I F S L L A I A I D R Y I A I R I P L
Y K L T P A Q W F L R E G S M F V A L S A S V F S L L A I A I E R Y I T M L K M K
W A F G D A G C R G Y Y F L R D A C T Y A T A L N V A S L S V A R Y L A I C H P F
W Y F G N F L C K A V H V I Y T V N L Y S S V W I L A F I S L D R Y L A I V H A T
W D F G N T M C Q L L T G L Y F I G F F S G I F F I I L L T I D R Y L A V V H A V
W P F G D V L C K I V L S I D Y Y N M F T S I F T L T M M S V D R Y I A V C H P V
W P F G N I L C K I V I S I D Y Y N M F T S I F T L C T M S V D R Y I A V C H P V
W P F G N A L C K T V I A I D Y Y N M F T S T F T L T A M S V D R Y V A I C H P I
W P F G E L L C K A V L S I D Y Y N M F T S I F T L T M M S V D R Y I A V C H P V
W Q F G S E L C R F V T A A F Y C N M Y A S I L L M T V I S I D R F L A V V Y P M
G P L R T F V C Q V T S V I F Y F T M Y I S I S F L G L I T I D R Y Q K T T R P F
H Q S N V G W C R L V T A A Y N Y F H V T N F FW M F G E G C Y L H T A I V L T -
S D G A V A G C R V A A V F M Q Y G I V A N Y C W L L V E G L Y L H N L L G L A -
- - - T T T S C Y LQ R L L V G L S S A M C Y S A L V T K T N R I A R I L A G S K
- - - K Q I Y C Y LQ R I G I G L S P A M S Y S A L V T K T Y R A A R I L A M S K
T S N E T L S C V I I F V I V Y Y A L M A G V V W F V V L T Y A W H T S F K A L G
25 30 35 40 45 50 55
W P F G N + L C + LW L S I D Y + N + T A S I F T L+ V I S I D R Y I A I T H P +
Figure 3.1: TM 3 alignment for the crystal structures. The blue column labels the n.50 residues
in BW numbering and the green color denotes the extent of the TM regions, which is very similar
across all classes. Prolines are highlighted in red. The last 5 sequences belong to classes B, C, and
F, and the rest to class A. There is very low sequence similarity between the different classes.
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The alignment of other TMs is shown on Figures figs. C.1 to C.7 in Appendix C.
3.2 Source of GPCR Sequences
Fredriksson [18] performed the first detailed phylogenetic analysis and classified 342 nonolfactory
human GPCR sequences into five main groups: rhodopsin, secretin, adhesion, glutamate, and friz-
zled/taste2. The phylogenetic tree based on this analysis is displayed on Figure 2.3.
The complete list of GPCRs is still not set and changes as new analyses of the human genome are
completed. Therefore we extended the list of candidate GPCRs with the proteins from the following
resources: [10, 8, 57]. Altogether we collected 836 candidate sequences, which can be categorized in
the following classes:
88 Aα 16 B 5 Vomeronasal
33 Aβ 22 C 25 Taste2
57 Aγ 11 F 11 Other
58 Aδ 33 Adhesion 8 Pseudogene
51 A-other 418 Olfactory
In this work, we label the rhodopsin group as class A. Since this is the largest group, we keep
Fredriksson’s subdivision to the 4 subgroups: α, β, γ, δ. Class A sequences, which were not included
in Fredriksson’s list, were labeled A-other in the present work. Class B labels the secretin group,
class C labels the glutamate group, and class F labels the frizzled group. The adhesion group has
sequences, which at the TM regions are similar to class B. The olfactory and vomeronasal receptors
are similar to class A. The main deviation from the classification of Fredriksson is observing that the
Taste2 group is more similar to class A than to class F, as will be argued in the following section.
Sequences which were collected from sources without classification were assigned to a class by
running the Basic Local Alignment Search Tool (BLAST) and searching for the most similar proteins.
A curious case is the protein GPR157 (Uniprot ID Q5UAW9), which is most similar to class B, but
its TM1 has a gap in the alignment to class B. However, the TM1 aligns well to the class A TM1,
so this protein is a hybrid between these two classes.
We identified 11 Other proteins (they are listed in Appendix D) for which the BLAST search
does not return any sequences with already assigned classes. To identify a good alignment for such
individual sequences, one could search for similar sequences in different species, and then average
over the sequence variation when trying to find a good alignment. However, this has to be done for
each protein separately, so we skip it in our general analysis.
Finally, some of the candidate sequences were ruled to be pseudogenes, because they align well
with some known GPCR, but miss one or more TM regions.
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3.3 Extension of Alignment to All Known GPCR Sequences
The approximate positions of the TM regions are already annotated in the Uniprot database as
predicted by the TMHMM program [65]. The prediction is quite noisy, and even for similar proteins
which align well, it typically differs by 5-8 residues and sometimes even misclassifies a TM. However,
the overall trend clearly determines the approximate TM location and allows us to judge the quality
of the alignment of several proteins. If there are gaps in the TM regions, the alignment cannot be
used to successfully create homology models.
First, we try to align all 828 sequences of the GPCR superfamily using a multiple sequence
alignment program Clustal Omega [66]. However, the overall sequence conservation is very low, and
so the resulting alignment has many large gaps, and even some highly conserved residues end up
aligned incorrectly. In order to avoid this problem, we try to align only class A sequences (705,
including olfactory), and again the resulting alignment has large gaps even in the TM region. It
seems that the large variability of the loop region is what confuses the alignment algorithm.
Fortunately, sequences within individual subgroups can be aligned using Clustal Omega without
large gaps in the TM regions. We take these individual subgroup alignments and fix them into a
profile. We then align any two profiles to see how similar the two groups are.
A profile alignment of Aα to each of the other class A groups (Aβ, Aγ, Aδ) has no gaps in the
TM regions, and also gives correct alignment of the BW .50 residues.
The multiple sequence alignment of the group A-other showed gaps in the TM regions for several
proteins (Uniprot IDs: Q96P67, Q8TDU6, Q16570, Q86SM8, Q9NS66, Q9NS67, P60893, Q86SM5),
so a separate profile is created for these sequences. Both profiles of the A-other proteins aligned to
Aα without any gaps in the TM region. The profile of olfactory receptors aligned well to Aα as
well. The Vomeronasal and Taste2 groups were more problematic, and are discussed in the following
section.
The profile of the adhesion group aligns well to class B and class B is aligned to class A using
the structural analysis, as discussed before. Aligning profiles of Aα and B does not yield meaningful
alignment, because the TM regions are offset and there are many gaps in the TM regions. Similarly,
aligning classes A and C or A and F does not yield meaningful alignment.
Once the alignment is fixed, the TM lengths for new proteins are taken as the average TM lengths
from the available structures in the same class. For example, for TAS1 proteins the predicted TM
length is the average TM lengths of GMR1 and GMR5; and for TAS2 the average TM lengths of
15-20 class A structures.
Appendix D has the complete listings of all the proteins and their alignment suitable for building
homology models or starting sampling of the TM bundle.
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Group	  1 Group	  2 TM -­‐5 -­‐4 -­‐3 -­‐2 -­‐1 0 1 2 3 4 5
Vomeronasal A-­‐alpha TM1 0.21 0.20 0.23 0.26 0.29 0.33 0.23 0.22 0.24 0.25 0.23
Vomeronasal A-­‐alpha TM2 0.21 0.24 0.20 0.27 0.26 0.35 0.23 0.22 0.27 0.23 0.27
Vomeronasal A-­‐alpha TM3 0.22 0.20 0.21 0.21 0.16 0.36 0.16 0.20 0.21 0.14 0.17
Vomeronasal A-­‐alpha TM4 0.23 0.23 0.23 0.25 0.25 0.33 0.22 0.23 0.21 0.27 0.19
Vomeronasal A-­‐alpha TM5 0.20 0.24 0.20 0.22 0.28 0.25 0.21 0.28 0.24 0.21 0.19
Vomeronasal A-­‐beta TM5 0.25 0.23 0.22 0.22 0.27 0.28 0.20 0.25 0.24 0.23 0.20
Vomeronasal A-­‐gamma TM5 0.22 0.23 0.23 0.23 0.26 0.30 0.21 0.24 0.23 0.22 0.20
Vomeronasal A-­‐delta TM5 0.21 0.23 0.23 0.23 0.25 0.30 0.22 0.22 0.23 0.23 0.18
Vomeronasal B TM5 0.25 0.26 0.23 0.22 0.25 0.31 0.29 0.26 0.24 0.27 0.25
Vomeronasal C TM5 0.25 0.25 0.22 0.24 0.24 0.27 0.26 0.24 0.26 0.16 0.15
Vomeronasal F TM5 0.22 0.25 0.24 0.28 0.17 0.24 0.27 0.28 0.25 0.23 0.22
Vomeronasal A-­‐alpha TM6 0.24 0.27 0.28 0.23 0.26 0.39 0.25 0.21 0.26 0.23 0.21
Vomeronasal A-­‐alpha TM7 0.20 0.21 0.19 0.22 0.24 0.31 0.19 0.21 0.20 0.23 0.16
Offset
Table 3.1: Testing the robustness of the alignment of the Vomeronasal receptors with the other
groups. The table shows similarity between TMs averaged over all pairs of sequences formed from
group 1 and group 2. Red denotes high similarity, blue low smilarity.
3.4 Bitter Taste and Vomeronasal Receptors
The profile of the vomeronasal group aligns better with class Aα compared to classes B and C, but
there is still a gap of length 2 near the center of TM5. We remove the gap in such a way that
the residue which aligned with 5.50 stays fixed. To check that this is indeed the best alignment we
explore small changes in the alignment by shifting individual TM by -5 – +5 residues. In Table 3.1
we can see that for TMs 1 to 4, the current alignment gives the highest sequence similarity with
Aα, so the alignment of these TMs is correct. However, for TM5, the alignment shifted by -1 or +2
residues gives higher similarity with Aα. Nevertheless, the similarity with groups Aβ, Aγ, Aδ, and
B is the highest for the current alignment. We therefore keep the current choice.
We performed similar analysis for the Taste2 receptor, for which adjustments had to be made.
The profile alignment of Taste2 with Aα has some gaps, but it is still the best alignment (i.e., it
has the fewest gaps) compared to aligning to classes other than class A. TM3 has two gaps in the
alignment: Gap of length 4 in the middle of TM3, and gap of length 5 at the DRY motive. As the
first iteration we kept the alignment fixed on residue 3.50, then we computed the similarity to other
groups for -5 – +5 residue shifts. The shift by +3 residues gives better similarity and so it was kept.
See Table 3.2 for the computed similarities after the shift has been made. All class A subclasses
favor this new choice, as the highest similarity has offset 0. Class B would favor shift by 2 residues,
but the similarity is less than 30%.
TM4 has low sequence similarity, and in particular highly conserved Trp is not present in Taste2.
Again as a starting point we keep the alignment at 4.50, but later had to adjust it by 4 residues.
Table 3.2 shows the similarity after this shift has been made. For TM4 the similarity is only slightly
higher at the new best offset than at nearby offsets.
Taste2 TM6 showed partially conserved motif IYFLS, with S being aligned with P6.50, which
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Group	  1 Group	  2 TM -­‐5 -­‐4 -­‐3 -­‐2 -­‐1 0 1 2 3 4 5
Taste2 A-­‐alpha TM1 0.23 0.24 0.27 0.31 0.30 0.34 0.28 0.27 0.29 0.28 0.23
Taste2 A-­‐beta TM1 0.25 0.26 0.29 0.31 0.26 0.37 0.28 0.25 0.32 0.29 0.23
Taste2 A-­‐gamma TM1 0.25 0.25 0.31 0.28 0.27 0.39 0.28 0.25 0.31 0.29 0.23
Taste2 A-­‐delta TM1 0.24 0.24 0.28 0.25 0.27 0.36 0.26 0.24 0.30 0.27 0.25
Taste2 B TM1 0.24 0.30 0.31 0.23 0.26 0.29 0.28 0.25 0.26 0.29 0.23
Taste2 C TM1 0.26 0.22 0.25 0.25 0.27 0.36 0.27 0.26 0.29 0.26 0.27
Taste2 F TM1 0.20 0.16 0.16 0.17 0.27 0.25 0.22 0.20 0.25 0.22 0.23
Taste2 A-­‐alpha TM2 0.27 0.23 0.23 0.28 0.25 0.39 0.27 0.27 0.22 0.27 0.27
Taste2 A-­‐beta TM2 0.30 0.23 0.26 0.27 0.23 0.38 0.27 0.28 0.22 0.26 0.29
Taste2 A-­‐gamma TM2 0.29 0.22 0.22 0.30 0.22 0.35 0.26 0.27 0.21 0.24 0.23
Taste2 A-­‐delta TM2 0.28 0.23 0.24 0.30 0.23 0.33 0.26 0.27 0.23 0.26 0.24
Taste2 B TM2 0.23 0.23 0.14 0.22 0.23 0.33 0.23 0.22 0.27 0.25 0.29
Taste2 C TM2 0.19 0.23 0.21 0.20 0.33 0.23 0.24 0.25 0.29 0.30 0.24
Taste2 F TM2 0.20 0.19 0.18 0.23 0.22 0.31 0.25 0.28 0.20 0.25 0.27
Taste2 A-­‐alpha TM3 0.21 0.21 0.20 0.22 0.18 0.30 0.19 0.23 0.25 0.19 0.14
Taste2 A-­‐beta TM3 0.21 0.22 0.20 0.22 0.18 0.31 0.21 0.20 0.24 0.19 0.16
Taste2 A-­‐gamma TM3 0.20 0.23 0.21 0.21 0.20 0.36 0.22 0.22 0.25 0.22 0.18
Taste2 A-­‐delta TM3 0.19 0.23 0.20 0.21 0.17 0.33 0.22 0.21 0.24 0.20 0.17
Taste2 B TM3 0.17 0.20 0.20 0.17 0.24 0.26 0.21 0.29 0.25 0.19 0.19
Taste2 C TM3 0.16 0.22 0.17 0.24 0.24 0.18 0.17 0.23 0.22 0.23 0.20
Taste2 F TM3 0.21 0.22 0.25 0.22 0.21 0.28 0.28 0.28 0.24 0.27 0.18
Taste2 A-­‐alpha TM4 0.30 0.31 0.30 0.29 0.28 0.33 0.28 0.28 0.23 0.26 0.24
Taste2 A-­‐beta TM4 0.32 0.28 0.28 0.27 0.28 0.34 0.29 0.29 0.26 0.30 0.25
Taste2 A-­‐gamma TM4 0.27 0.31 0.28 0.31 0.30 0.31 0.28 0.29 0.27 0.27 0.26
Taste2 A-­‐delta TM4 0.28 0.29 0.30 0.32 0.32 0.31 0.28 0.29 0.28 0.28 0.26
Taste2 B TM4 0.20 0.21 0.27 0.25 0.27 0.29 0.26 0.25 0.20 0.23 0.22
Taste2 C TM4 0.32 0.30 0.30 0.31 0.32 0.33 0.34 0.31 0.32 0.31 0.29
Taste2 F TM4 0.14 0.26 0.25 0.26 0.20 0.23 0.26 0.27 0.23 0.26 0.29
Taste2 A-­‐alpha TM5 0.25 0.30 0.23 0.24 0.28 0.32 0.27 0.25 0.23 0.27 0.24
Taste2 A-­‐beta TM5 0.27 0.28 0.23 0.26 0.25 0.35 0.27 0.22 0.24 0.25 0.26
Taste2 A-­‐gamma TM5 0.26 0.29 0.23 0.24 0.28 0.37 0.26 0.23 0.25 0.25 0.25
Taste2 A-­‐delta TM5 0.23 0.28 0.24 0.24 0.27 0.37 0.26 0.24 0.24 0.26 0.25
Taste2 B TM5 0.23 0.33 0.32 0.27 0.27 0.32 0.30 0.27 0.35 0.35 0.25
Taste2 C TM5 0.28 0.28 0.25 0.25 0.25 0.23 0.27 0.20 0.23 0.26 0.21
Taste2 F TM5 0.21 0.29 0.24 0.29 0.26 0.29 0.20 0.28 0.32 0.25 0.20
Taste2 A-­‐alpha TM6 0.23 0.25 0.29 0.23 0.22 0.33 0.24 0.24 0.29 0.34 0.24
Taste2 A-­‐beta TM6 0.24 0.31 0.29 0.25 0.25 0.35 0.23 0.24 0.28 0.33 0.27
Taste2 A-­‐gamma TM6 0.24 0.26 0.29 0.24 0.24 0.35 0.24 0.25 0.31 0.35 0.26
Taste2 A-­‐delta TM6 0.24 0.25 0.29 0.23 0.23 0.33 0.24 0.25 0.29 0.33 0.25
Taste2 B TM6 0.25 0.21 0.31 0.29 0.24 0.37 0.31 0.22 0.30 0.32 0.22
Taste2 C TM6 0.24 0.27 0.19 0.23 0.23 0.30 0.27 0.22 0.29 0.32 0.27
Taste2 F TM6 0.17 0.30 0.34 0.22 0.27 0.32 0.27 0.20 0.23 0.23 0.24
Taste2 A-­‐alpha TM7 0.21 0.23 0.22 0.25 0.24 0.27 0.18 0.20 0.17 0.25 0.16
Taste2 A-­‐beta TM7 0.19 0.23 0.23 0.26 0.26 0.29 0.20 0.23 0.17 0.23 0.16
Taste2 A-­‐gamma TM7 0.18 0.24 0.22 0.26 0.24 0.29 0.18 0.21 0.14 0.25 0.14
Taste2 A-­‐delta TM7 0.20 0.26 0.23 0.26 0.22 0.26 0.18 0.20 0.19 0.24 0.16
Taste2 B TM7 0.22 0.24 0.22 0.22 0.27 0.22 0.17 0.20 0.20 0.19 0.15
Taste2 C TM7 0.25 0.26 0.24 0.25 0.26 0.22 0.24 0.22 0.22 0.20 0.21
Taste2 F TM7 0.23 0.18 0.20 0.23 0.24 0.26 0.29 0.23 0.22 0.20 0.19
Offset
Table 3.2: Testing the robustness of the alignment of the Taste2 receptors with the other groups.
The table shows similarity between TMs averaged over all pairs of sequences formed from group 1


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.2: Phylogenetic tree based on TM similarity only (loops were ignored). Color coding
denotes the GPCR class. Proteins with known crystal structure are emphasized with a dot. The
tree was visualized using the Iterative Tree of Live toolkit [67].
we kept as an initial try. This choice is kept in Table 3.2. However, we see that an offset of +4
residues, which correspond to one turn shift (the motif IYFLS aligns Ile with P6.50), also gives high
similarity. Based solely on sequence similarity we cannot distinguish which alignment is better, and
therefore both cases should be considered when building homology models.
3.5 Phylogenetic Tree
Based on the constructed alignment, we can compute the similarity for each of the two sequences
using the weights from the BLOSUM62 matrix, and the similarities can be used as a distance metric
to cluster the proteins. We used the unweighted pair-group clustering algorithm (implemented in
Jalview [68]), which iteratively extends clusters by finding a non-member sequence with the lowest
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average dissimilarity over the cluster members. Figure 3.2 shows the phylogenetic tree constructed
by this clustering algorithm.
The branches near the root of the tree are very sensible: First class C separates, then class
B and adhesion proteins branch off, and then class F. The rest of the tree contains class A-like
sequences. Except for several outliers, the first major branches to separate are the sensory receptors:
Vomeronasal, Taste2, and Olfactory. In the olfactory branch, the first split separates the fish-like
receptors (families 51-56) from the tetrapod-like receptors (families 1-13). The subdivision of the
rest of the class A family does not exactly follow the α− δ subclasses, but it is close.
Near the leaves (i.e., for closely related proteins), the displayed tree might not be the best clas-
sification, since the computation of similarity ignored loops. For related proteins, it is advantageous
to align loops as well, since loops often interact with ligands, and therefore can determine receptor
specificity. However, for very dissimilar proteins present in the GPCR super-family, aligning the
loops does not provide any useful information.
3.6 Loop Alignment
In such a large protein family loops can be very diverse, and so a meaningful alignment of the loop
regions could only be done for smaller subgroups. The intracellular side of the GPCRs interacts
with the G-proteins, and thus we expect the intracellular loops to be similar among the proteins.
Extracellular loops adapt each protein to its particular function and thus are more variable.
In many cases there are several disulfide bonds in the extracellular loops keeping the loops in a
compact conformation. If we can find a conserved disulfide link, it significantly limits the possible
conformations of the loops. In particular, there is a highly conserved disulfide bond between TM3
and loop EC2. This bond is important even for folding the protein in the membrane. For example, in
HCAR1 [64] mutating cysteines of this conserved bond prevent the protein from being assembled in
the membrane. However, mutating other cysteines in the loop regions, which are probably involved
in separate disulfide bonds, only interrupts the protein sensitivity to the ligand. The constraints
coming from conserved or experimentally observed disulfide bonds should be used in constructing
the loops.
In fact, the longer loops are expected to be quite flexible at body temperature, as they are
often not resolved in the crystal structures. Furthermore, one can expect the loop conformations
to be influenced by crystal packing. We compared how loops differ between several different crystal
packings for proteins for which crystal structures in multiple crystal packing are available. In the
case of A2A, we indeed observed two different conformations of the EC2 loop in different crystal
packings. However, all loops of β2AR and RHO seem to have loops of very similar conformations in
the different crystal structures.
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3.7 Size of Helix Movements
By careful analysis of the inter-helical contacts we constructed a unique alignment between all the
GPCR protein, from which new homology models can be derived. For structure prediction we would
like to know how far the homology models are from the target structure. In this section we compare
the variability of the TM bundles, when we treat the individual TM helices as rigid bodies. In
particular we are interested in how large moves should be sampled, in order to effectively model the
target protein starting from the homology model.
The Figure 3.3 shows the observed move sizes. Each pair of known structures was first aligned
together, then each helix of the first protein was individually aligned to the corresponding helix
of the second protein and the size of the move was measured. The center of mass translation was
broken down into the direction along the helical axis and a direction perpendicular to it. The ‘tilt of
axis’ measures how much axis 1 had to be rotated to axis 2. And finally the ‘rotation around axis’
measures the necessary rotation around the axis to map the corresponding atoms to each other.
From Figure 3.3 we see that the maximal move sizes, which need to be considered, get smaller
as the similarity of the TM sequence increases. If we are predicting a structure starting from a
homology model with higher than 50% similarity, then we only need to consider translating the
helices up to 1.5 A˚ in any direction, tilting them up to 10, and rotating around their axis by 40.
This is a very useful bound for refining homology models.
The same comparison can be applied to one protein in multiple conformations. The red points
in Fig. 3.3 show the magnitude of rigid body moves underwent during activation for the 3 available
pairs of active-inactive structures. Activation involves mainly the movement of TMs 5, 6, and 7.
The computation of the move sizes ignores the bending of TM6 during activation, so it should be
understood as an approximate description only.
3.8 Conclusion
We constructed the sequence alignment of the transmembrane regions for most known human
GPCRs, which is a promising starting point for structure prediction. For a protein in question
one can build homology models based on any of the available templates by mutating the corre-
sponding amino acids. One of the most visible structural errors in the predicted structures comes
from misalignment of prolines, since prolines often cause kinks in the long helical TM regions. Such
errors can be avoided by choosing a template with the least misaligned prolines. However, most of
the differences among the proteins cannot be resolved only by using a suitable template, and one
needs to refine the structure of the initial homology models. GPCRs are too large (> 300 residues)
for exploring larger conformational changes using molecular dynamics. In the next chapter, we
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Translation perpendicular to axis
Figure 3.3: Magnitude of the rigid body moves of the helices necessary to map one structure to
another. All TMs 1-7 from all available structure pairs were compared. The coordinates systems is
defined in the text. The maximal observed deviation is approximately proportional to the sequence
similarity of the two compared TMs, and it follows the same trend within class A (blue points) and
across the GPCF superfamily (green points). The red points, which correspond to the active-inactive
structure pairs, show rigid body moves caused by receptor activation.
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4.1 GPCR Structure Prediction
We begin this chapter by summarizing possible approaches to protein folding. As discussed in the
introduction, the number of possible protein conformations scales exponentially with the length of the
proteins. Small proteins with about 50 residues can sometimes be folded using molecular dynamics
(MD) by directly simulating the protein folding process in time. Some fast folding proteins fold
on microsecond timescale, but most natural proteins fold at millisecond timescale or longer. For
example, the folding time for ubiquitin, which has 76 residues, is about 3ms. Piana et al. [1]
simulated in total 8 ms of ubiquitin MD and observed 2 folding and 8 unfolding events. Reaching
millisecond timescale requires state of the art supercomputers, and for large proteins we would likely
need to simulate even longer MD. Another timescale that comes into play for large proteins is the
rate of protein synthesis, which is only about 10 residues per second. Thus the N-terminus has
several more seconds to assemble, while the protein is still being synthesized. This is relevant for
GPCRs because they are inserted into the membrane helix by helix: first TM1, then TM2 and 3,
then TM4 and TM5, and finally TM6 and TM7. It is possible that the ensemble of helices 1-5
creates intermediate states, which are important to the later formation of the whole 7 TM bundle.
Simulating the complete membrane insertion would requite 10 s or longer of MD, which is out of
the reach of current computers.
Instead of simulating the physical dynamics directly, one can take shortcuts. Larger proteins
with about 100 residues can often be solved with the Monte Carlo method combined with fragment
assembly or other sampling techniques [2]. The most successful methods rely on assembly of frag-
ments, which are shapes of short amino chains extracted from the PDB crystal structure database.
Since the number of solved structures in the database is increasing — it is almost 100,000 currently
— the library of possible motives is more and more comprehensive. Unfortunately, there are only
a few solved membrane structures available, and therefore only few motives specific to membrane
proteins have been observed. A particularly successful Monte Carlo structure prediction toolkit
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is Rosetta [69]. Besides the amino acids fragments, Rosetta also collects distributions of atomic
distances and torsion angles from the PDB database, which are then converted into energy terms.
The potentials cannot be well calibrated to the protein-membrane interface, however, because there
are only few membrane proteins in the PDB database. The Rosetta community attempted to im-
plement de novo membrane protein structure prediction with a program called Membrane AbInitio
[3, 70, 17], but the effort was discontinued. The lack of known structures makes predicting new ones
more challenging.
In the next section we discuss possible approaches to protein structure refinement, and in the
rest of this chapter we discuss the Bihelix and Trihelix sampling methods, which use several approx-
imations to simplify the GPCR structure prediction problem.
4.2 Structure Refinement
To solve the structure of a large protein, it is best to start with a structure of a related protein, and
then try to refine it with MD or other sampling methods. Indeed, the current most successful GPCR
structure prediction methods are based on homology modeling [5]. As discussed in Section 2.3, the
crystal structures solved since 2008 are very similar to each other in the TM region. The TM RMSD
is ∼2.5 A˚ - 3.5 A˚. Thus homology models built with the correct sequence alignment should have
TM RMSD in a similar range. Nevertheless, the refinement of the initial model below 2 A˚ remains
challenging. First, let us consider the simulation timescales that would guarantee refinement with
MD.
There are many MD simulations of the β2 receptor which can help us estimate how long it takes to
change the conformation. Rosenbaum et al. [15] performed 30µs long MD of the β2 active state. At
about 11µs from the start, the protein went from the active state to the inactive one. More recently
in 2014, Kohlhoff et al. [71] performed an exhaustive exploration of the activations pathways of
β2 using large Google computational resources. The cumulative time of their simulations was 2ms,
which can serve as an estimate of the timescale necessary to find conformational changes in a GPCR.
Refining a homology template using MD would likely take an order of magnitude more time.
A more successful refinement protocol is the Fast Relax algorithm [72] from the Rosetta macro-
molecular modeling suite. The algorithm cycles through side chain repacking and minimization,
while gradually increasing the Van der Waals repulsion until its full value. This algorithm is typ-
ically used on soluble proteins up to 100 residues in length. Since the typical GPCR protein with
loops (∼350 residues) is too large, and the fold of the loops is often unknown, we try this approach
to refine the TM bundle without the loops (∼200 residues).
The Fast Relax protocol samples large changes in the side chain packing by decreasing the Van




Figure 4.1: Separation of the 7 TM bundle into interacting parts for Bihelix. Images from [6].
relative to the X-ray reference. The missing loops, which would normally constraint the positions of
the helices, allow separation of the helices as the Van der Waals repulsion is returned to its full value.
In order to avoid this problem, we add constraints to the starting helix positions. The constraints
do not help in discriminating the correct structure because either the constraints are too weak to
affect the energy, or they are too strong and do not allow any significant movement.
Fast Relax introduces dramatic changes to the protein structure and in order for the minimization
to not disassemble the protein, it is important that there is only one amino acid chain, which
cannot break. Furthermore, for small proteins the strong hydrophobic forces keep the protein from
disassembling. If we do not allow steps which disassemble the TM bundle, then the loops can be
ignored. In the next section, we consider a very different approach where only a small subset of
coordinates is sampled.
4.3 Complete Sampling Approach
Before the year 2008, the only solved GPCR structure was rhodopsin. At that time, the structural
similarities of rhodopsin to other GPCR proteins could only be inferred from sequence comparisons.
Because the sequence similarity of proteins in the GPCR superfamily was very low, it was not clear
how large the differences between different GPCR structures were.
In order to refine homology models, Abrol et al. [73, 74] developed the Bihelix sampling method.
This method ignores loops of the helical bundle, and only samples the rotation of each helix around
its axis in 30° increments. The total number of conformations is too large to build directly, so a mean
field approach is used to approximate the energy of the seven helix bundle from pairwise interactions
energies between neighboring helices. Fig. 4.1a shows the 12 helical interactions in the seven helix
bundle. For each pair of interacting helices, the backbone atoms are first rotated around the helical
axes to the desired angles θi, θj ; side-chains are repacked using a side-chain packing algorithm; then
the structure is minimized in the desired force field; and finally the energy of the helix pair is split
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Sidechain placement Scream Scwrl Rosetta
Force field Dreiding Amber Rosetta
Bihelix Combihelix Bihelix Combihelix Bihelix Combihelix
A2A 1 1 168 1 1 1
β2 2 1 — 1 1 1
PAR1 1 1 2 1 1 1
P2Y12 2 1 133 1 1 1
RHO 1 4 1 2 1 1
Table 4.1: Test if the Bihelix method can select the correct structure when starting to sample from
a crystal structure. The table shows the rank of the all zero structure after the Bihelix stage and
after the Combihelix stage; 1 means that the all zero structure has the lowest energy, and so was
correctly identified. The energies were evaluated using different combinations of side-chain placement
algorithms and force fields: Scream [75], Scwrl [76], Dreiding [77], Amber [78], Rosetta [69].
into the energy of the i-th helix Eiji , energy of the j-th helix E
ij
j , and their interaction energy E
ij
i−j .
The energy of the whole bundle is then approximated as:
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+ . . . (9 other pairwise helix interactions).
In this manner the mean field energy for all 127 = 35 · 106 conformations is computed from only
12 · 122 = 1728 constructed structures.
To test whether the mean field energy can distinguish the native conformation, we start the
Bihelix sampling for several proteins with known structure. The reference structure is the native
conformation, so the desired solution has all θi angles 0. Table 4.1 shows the performance of the
Bihelix sampling with several side-chain packing algorithms and several different force fields. For
example, the Scream side-chain packing together with the Dreiding force field is able to identify the
native structure as the first or second lowest energy from all 35 · 106 conformations.
After the approximate Bihelix stage, we select the 2000 lowest energy conformations for a more
accurate energy evaluation: we explicitly build the bundles, repack the side-chains, and evaluate
the bundle energies. The rank of the all zero conformation is shown in the Cobihelix column
of the Table 4.1. We see that Combihelix recovers the native structure in all cases except for
rhodopsin. The selected rhodopsin crystal structure has a covalently bound molecule retinal, so the
rhodopsin structure without the retinal molecule might be different. In summary, the two stage
energy evaluation (Bihelix and Combihelix) is able to resolve the native structure with the used
force fields.
We described this algorithm in detail because it is very uncommon in the protein modeling
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(a) Coordinate system for each helix.
θ -15° 0° +15°
α, β -7° 0° +7°
z -2 A˚ 0 A˚ +2 A˚
(b) Step sizes in the present Trihelix runs.
Figure 4.2
community. Bihelix performs complete sampling on a small set of discretized coordinates. The
complete sampling is done in several stages: first, approximate energy is used for all conformations,
and second, a more accurate energy is evaluated for a smaller set of structures. In order for this
scheme to work, the coordinate grid has to be large enough, or the energy function will not be able
to distinguish the correct structure as the lowest energy structure. On the other hand, if the grid
is too coarse, it is likely that the correct structure is the trivial all zero conformation. The Bihelix
sampling was a novel way to study GPCR proteins when only the rhodopsin structure was available.
At present good sequence alignments and several GPCR structures are commonplace, thus the initial
homology models are better quality than the resolution of the Bihelix sampling.
In later development, Bray [6] refined the Bihelix sampling to a finer grid of points and also
allowed for tilts of the helices. The larger computational cost was resolved by adding an intermediate
mean field approximation, where only the low scoring conformations for each 4 helix bundle are kept
(see Quadhelix diagram in Fig. 4.1b). This modified approach selects near native states, when the
helix shapes from the target protein are provided. However, this approach did not manage to refine
a homology model without prior knowledge of the helix shapes of the target protein. Thus, as far as
structure prediction, the original homology model is better than the output of the modified Bihelix
sampling.
In the next section we describe our algorithm for GPCR structure refinement, which uses the
same ideas of complete sampling on finite grid, but samples more degrees of freedom with more
relevant step sizes.
4.4 Trihelix Sampling
A detailed analysis of the GPCR crystal structures suggests that the rigid body manipulations of
the individual helices are suitable degrees of freedom, if one considers translations as well (Figure
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3.3). Thus, in addition to the 3 rotational degrees of freedom for each helix, we add translations of
the helix center of mass. To limit the computational requirements, we only consider the translations
along the helical axis, which makes 4 degrees of freedom per helix. The coordinate system for each
helix is shown in Fig. 4.2. Sampling 3 points per degree of freedom gives 34 = 81 conformations per
helix, and 817 = 2.3× 1013 conformations for the whole bundle.
Bihelix stage. First, we explicitly build models for 12 helix pairs for all 81 ∗ 81 conformations
(78,732 in total) and evaluate their energies. Based on these energies, we use the mean field approx-
imation as in Equation 4.1 to compute the energy of all the conformations of the four helical bundle
TM2-3-6-7. We keep the lowest lying 106 conformations and compute the mean field energy of all
five helical bundles TM2-3-5-6-7 for each TM5 conformation. We again keep the lowest lying 106
conformations and add all conformations of TM4 to form bundle of 6 helices TM2-3-4-5-6-7. Finally,
for the lowest lying 106 conformations we add all conformations of TM1, to form the complete seven
helix bundle.
Then, starting from the lowest energy bundle conformations, we pick 20 conformations for each
helix.
Trihelix stage. The side-chain placement, when only two helices are present, is often not accurate,
and so to obtain better side-chain placements within a reasonable time, we build all bundles of the
interacting three helices. With the limited set of 20 conformations per helix, we explicitly build
all possible helical triplets (6 ∗ 203 = 48000 conformations). The selected conformations allow 207
different bundles. We evaluate the full bundle energies based on the mean field approximation from
the triplet energies (Eq. 4.2), and keep the 2000 lowest energy conformations for the full bundle
stage.
E(θ1, θ2, θ3, θ4, θ5, θ6, θ7) =E
127
1−2(θ1, θ2, θ7) + E
127
1−7(θ1, θ2, θ7) +
1
2
E1272−7(θ1, θ2, θ7) (4.2)
+ E1271 (θ1, θ2, θ7) +
1
3
E1272 (θ1, θ2, θ7) +
1
3




E2372−3(θ2, θ3, θ7) +
1
2







E2372 (θ2, θ3, θ7) +
1
5
E2373 (θ2, θ3, θ7) +
1
3
E2377 (θ2, θ3, θ7)
+ . . . (4 other trihelix bundles)
Full bundle stage. We build the 2000 structures explicitly and evaluate their energies. These
structures give the spectrum of low lying conformations and the lowest energy structure is the
predicted model.
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(a) TM1 of the PAR1 crystal structure (green)
serves as reference helix with a proline kink. The
homology model of TM1 based on β2 template (red)
with no proline kink minimizes to the blue structure
with an almost exact proline kink.
(b) Clash in a trihelix bundle (grey) is resolved by
change in backbone torsion (blue), not by moving
the helices apart.
Figure 4.3: Examples of the efficiency of torsional minimization.
4.4.1 Implementation
This protocol uses rigid body manipulations, sidechain placement, and minimization. We use Py-
Rosetta [79, 80] as a convenient way to perform all the steps in memory. We use the Talaris 2013
scoring function, and set the weight of the Lazaridis-Karplus solvation energy to 0, since most of
the TM bundle is exposed to the lipid membrane and not water. Energy is then reported in REU
(Rosetta energy units), which approximately equal kcal/mol.
Energy for each conformation is evaluated in the following way: first, the backbone atoms of each
helix are moved as rigid bodies to the desired conformation using numpy [81]; then, the sidechains
are repacked using Rosetta’s default repack algorithm [82]; after that, sidechains are minimized using
the Davidon-Fletcher-Powell minimizer (‘dfpmin armijo nonmonotone’); finally, the whole structure
is minimized using the same minimizer. Before the final minimization, we add harmonic constraints
on the CA atoms to their positions after the rigid body move.
Since the Rosetta’s sidechain repack algorithm is a Monte Carlo annealing with random outcomes,
we repeat this procedure 3 times, and keep the lowest achieved energy.
4.4.2 Torsional Minimization
The Bihelix method has difficulty getting the helix shape correct. Particularly problematic are
helical kinks and irregular turns near proline residues, because Cartesian minimization, which is
used in Bihelix, resolves the clashes locally. We use torsional coordinates, where the atom positions
are determined by torsion angles relatively to the bonded atoms. The minimizer implemented in
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the torsional coordinates can resolve some local clashes with moves that have a global effect. Figure
4.3a shows a successful minimization of a helix with one proline kink. Furthermore, when using
the torsional minimizer with the nearby helices present, the helix shapes mold to fit their local
environment (example shown in Fig. 4.3b).
In the absence of loops, the torsional minimizer sometimes makes large moves, separating the
helices and bending them away from each other. To supplement the role of loops and to tie the
bundle together, we add harmonic constraints to the CA atoms. The constraints keep balance
between helix flexibility and staying on the grid of the coordinates we are using to describe the helix
orientation. On the one hand, if the constraints are too high, the helix shapes are not allowed to
adjust. On the other hand, if the constraints are too low, the moves during minimization can be
larger than the coordinate grid size.
4.5 Testing the Trihelix Protocol
In the following section, we present a series of simulations designed to characterize the Trihelix
sampling method. In particular, we explore the coordinate grid size and the validity of the energy
model. The sampling is complete in the sense that all coordinates are considered at the Bihelix
level, but some low energy structures might still be missed if the coordinates are removed in the
Bihelix stage. We study in detail two cases: human adenosine receptor A2a (A2A) and human P2Y
purinoreceptor 12 (P2Y12). The A2A receptor is modeled by refining a homology template based
on another class Aα receptor, β2, which has TM sequence similarity 51% (identity 36%); the P2Y12
receptor is refined from the PAR1 receptor, which has TM sequence similarity 49% (identity 25%).
P2Y12 and PAR1 are the only receptors with known structure in the class Aδ, which is the class of
interest in the next chapter because it has the HCAR1 receptor in it.
The suitable translation and rotation magnitudes for refining homology models with 50% similar-
ity were analyzed in the previous chapter and can be found in Fig. 3.3. The ideal rigid body moves,
which optimally map the helices of the homology model to the crystal structure, involve all three
rotations and all three translations. In order to limit the computational cost we do not sample helix
translations in the membrane plane, but only the translation along the helical axis. The selected
move sizes are shown in Fig. 4.2.
The sampling of 3 steps for 4 degrees of freedom for all 7 helices takes approximately 200 CPU
hours at the Bihelix stage, 300 CPU hours at the Trihelix stage, and 200 CPU hours at the full
bundle level, in total about 700 CPU hours per protein. The computation is composed of evaluating
energies of many independent structures, thus scales to any number of processors.
Next we present an analysis of 4 types of simulations, gradually working towards the prediction of
one protein from another. First, to identify the resolution of the energy function, we try to refine the
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crystal structure itself. Next, we run two intermediate stages by using some degree of information
from the correct crystal structure. Finally, we perform full prediction as if the modeled protein was
currently unknown.
The many RMSD numbers in the following analysis should be compared to the RMSD of the
initial homology models for A2A and P2Y12: 1.85 A˚ and 2.23 A˚. We try to refine the homology
models, i.e., the goal is to decrease the RMSD.
4.5.1 Recovery of the Crystal Structure
At first, we start the Trihelix sampling from the A2A crystal structure itself. Figure 4.4 shows that
the starting structure is correctly identified as the lowest energy structure. We call the starting
structure all-zero, since all the coordinates are 0. The gap to the second lowest energy state is
1.2 REU. The scatter plot in Fig. 4.4 is similar to the energy funnel plot often seen in Monte
Carlo protein folding, but it is not as dense at the bottom, because we sample on discrete grid of
coordinates. Here the funnel means that only small errors in structure are made if the energy does
not distinguish the correct lowest energy state.
In the case of A2A reconstruction, the method finds the correct lowest energy structure. This is
not a trivial result, since this structure had to pass through both the Bihelix and Trihelix approxi-
mations.
Fig. 4.5 shows an analogous simulation for P1Y12, where the Trihelix sampling starts from the
correct P2Y12 crystal structure. In this case, the lowest energy structure has RMSD 0.77 A˚, but the
all-zero structure has the 8th lowest energy and RMSD 0.42 A˚ (after minimization). Nevertheless,
RMSD below 1A˚ is still very low. These two runs suggest that the energy model can be used to
identify structures similar to the crystal structure. In fact, for these two examples, the Trihelix
mean field energy identifies the same lowest energy structure as the full bundle energy.
4.5.2 Sampling with the Correct Helix Shape
In the previous subsection we have shown that if the helices are at the right positions and if they
have the right shape, the energy model can distinguish the native structure or find a structure very
close to the native one. Below, we separately analyze the importance of the correct helical shape
and of the correct helical positions. First, we run the Trihelix sampling on a hybrid template that
is formed by the correct A2A helices that are aligned to the orientation of helices in β2.
The starting hybrid template has RMSD 1.49 A˚ (from the A2A crystal structure). Figure 4.6
shows that the energy does not select the structure with the lowest RMSD from the sampled set,
but finds a structure with RMSD 1.52 A˚, which is a similar RMSD to the starting one. This
number should not be compared to 0, but to the best possible RMSD given the used restricted set
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θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-724.7 1 -701.2 39 0.41 0.32
-724.0 2 -700.0 38 0.55 0.30
-723.0 3 -698.3 39 0.43 0.33
-721.0 7 -698.3 36 0.68 0.65
-721.6 6 -696.7 39 0.57 0.28
-721.8 5 -696.5 36 0.56 0.66
-717.0 34 -696.0 38 0.75 0.72
-714.0 104 -695.8 39 0.46 0.34
-720.4 8 -695.8 38 0.55 0.30
-719.0 15 -695.6 35 0.69 0.38
Figure 4.4: Trihelix results for the A2A crystal structure when starting from itself. Scatter plot:
The blue points denote 2600 structures from the Trihelix run. The energy is in REU (Rosetta Energy
Units, approximately kcal/mol) and the RMSD is after structure minimization. The red + highlights
the lowest energy structure. The vertical line shows the RMSD of the initial homology model (before
minimization, here at 0). The green × shows the all-zero structure (after minimization, so its RMSD
is > 0). Table: The table lists the 10 lowest energy conformations. The colors denote values of the
sampled coordinates according to the color key in Fig. 4.2. The ‘number of contacts’ column is the
number of class A common contacts present in this structure (the conserved contacts are listed in
Fig. 2.8). The last two columns show RMSD to the correct crystal structure. RMSD of the binding
pocket is discussed in Section 4.5.5.
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θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-801.2 1 -757.1 39 0.77 0.64
-791.7 35 -757.0 39 0.90 0.82
-790.4 59 -756.8 39 0.47 0.42
-792.8 26 -754.9 39 0.66 0.53
-793.5 18 -754.9 39 0.45 0.35
-793.6 17 -754.5 38 1.57 1.69
-789.6 75 -753.2 38 0.92 0.89
-790.9 51 -752.1 39 0.42 0.37
-789.1 92 -751.7 39 0.50 0.42
-791.2 43 -751.3 38 1.00 0.96
Figure 4.5: Trihelix results for the P2Y12 crystal structure when starting from itself. Same legend
as for Fig. 4.4. The all-zero conformation has the 8th lowest energy.
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θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-697.9 24 -679.9 37 1.52 1.31
-701.2 3 -678.5 39 0.99 0.72
-701.5 2 -677.9 38 1.31 0.89
-695.3 111 -676.4 37 1.32 1.08
-699.0 12 -676.2 39 0.97 0.85
-697.4 28 -675.9 38 1.23 0.83
-691.9 578 -675.8 38 1.37 1.38
-693.4 275 -675.4 38 1.34 0.91
-694.1 210 -674.8 37 1.40 1.26
-693.1 326 -674.7 33 1.54 1.56
. . .
-659.2 37 0.95 0.76
Figure 4.6: Trihelix results for A2A when starting from a hybrid structure of A2A helices aligned to
the β2 crystal structure. Scatter plot: The blue points denote 2600 structures from the Trihelix
run. The energy is in REU and the RMSD is after structure minimization. The red + highlights the
lowest energy structure. The vertical line shows the RMSD of the initial homology model (1.49 A˚).
The green × was added after the Trihelix run and corresponds to the conformation, with ideal moves
rounded to the nearest grid coordinate. Table: The table lists the 10 lowest energy conformations
and the added rounded conformation. The colors denote values of the sampled coordinates according
to the color key in Fig. 4.2. ‘The number of contacts’ column is the number of class A common
contacts present in this structure (the conserved contacts are listed in Fig. 2.8). The last two
columns show RMSD to the correct crystal structure. RMSD of the binding pocket is discussed in
Section 4.5.5.
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θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-758.3 86 -727.3 36 1.36 1.88
-759.7 33 -725.9 36 1.70 1.77
-751.5 1747 -725.5 38 1.85 2.38
-765.2 3 -723.1 36 1.75 1.92
-756.7 194 -722.7 38 1.59 2.24
-751.4 1839 -721.8 38 1.52 1.78
-751.3 1877 -721.4 39 1.57 1.94
-752.5 1180 -721.1 38 1.78 2.25
-765.2 2 -720.8 35 1.68 1.66
-750.7 2313 -720.5 39 1.72 2.30
. . .
-686.3 36 1.15 1.12
Figure 4.7: Trihelix results for P2Y12 when starting from a hybrid structure of P2Y12 helices
aligned to the PAR1 crystal structure. Same legend as for Fig. 4.6. The starting RMSD is 2.02.
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of coordinates. To find a close conformation on the sampled grid of coordinates, we rounded the
ideal helical moves to the nearest grid point. This closest grid point is shown as a green × and is
specified in the bottom line of the table (Fig. 4.6). The grid point was not found among the low
energy structures from Trihelix, so we had to add it in the analysis step. However, the energy of
this structure is relatively high compared to other sampled structures, therefore it is not surprising
that the Trihelix energy did not pick it up.
An analogous simulation for P2Y12 starts at RMSD 2.02 A˚ and the energy selects structure with
1.36 A˚, which is a large improvement (Fig. 4.7). The rounded grid conformation has RMSD 1.15
A˚, smaller still, but its energy is higher.
In both cases, the full bundle stage was necessary to identify the lowest energy model. The
solution was only 24th and 36th, respectively, at the Trihelix level. Both models have accuracy near
RMSD 1.5 A˚.
4.5.3 Sampling with the Correct Helix Positions
Next, we consider a hybrid structure formed with the homology (incorrect) helices placed in the
crystal (correct) orientations. In this case, the starting structure (RMSD ∼ 1 A˚) cannot be improved
by the rigid body moves. We want to see whether the energy function selects this structure, or if
the helical positions are inconsistent with the helical shapes as a result of clashes.
Figure 4.8 shows the result for A2A. The initial RMSD is 1.16 A˚ (1.20 A˚ after minimization),
but this structure has very high energy. The lowest energy structure has RMSD 2.09 A˚, which is
surprisingly high. For this structure, we identify all the inter-helical contacts and compare them to
the 40 conserved contacts in class A, which are listed in Fig. 2.8. This structure has only 31 out of
them. Thus we reject the structure and consider models which are higher in energy. Only the 6th
model has more than 35 contacts, so we select it as the solution. Its RMSD is 1.85 A˚. To select this
structure we described a GPCR health heuristic, which rejects models with less than 35 inter-helical
conserved contacts.
Figure 4.9 shows the result for P2Y12. The starting structure has RMSD 0.97 A˚, and the Trihelix
sampling identifies a model with RMSD 1.75 A˚. This model has 35 inter-helical contacts, therefore
it passes the GPCR health heuristic.
In both studied cases, the initial structure has a low RMSD ∼ 1 A˚ because we placed the helices at
the optimal orientations, but the energy function does not select it. Instead, structures with RMSD
around 1.8 A˚ are selected (after using the GPCR health heuristic). This shows that removing the
information about the exact helical shapes is a major obstacle for structure refinement, and without
the correct helical shapes we cannot expect to improve homology models below about 1.8 A˚.
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A2A from A2A template with β2 AR helices
θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-693.4 74 -682.5 31 2.09 1.46
-688.8 1425 -681.2 28 1.99 1.22
-690.6 467 -680.3 29 1.93 1.20
-688.0 2150 -679.9 33 1.91 1.54
-693.2 86 -679.2 31 2.00 1.41
-694.3 36 -678.6 36 1.85 1.64
-689.4 1010 -678.4 34 2.11 1.47
-694.0 51 -678.1 38 1.79 1.26
-689.2 1109 -677.8 28 2.13 1.88
-690.9 383 -677.6 31 2.05 1.38
. . .
-631.7 29 1.20 1.09
Figure 4.8: Trihelix results for A2A when starting from a hybrid structure of β2 helices aligned to
the A2A crystal structure. Same legend as for Fig. 4.6. The starting RMSD is 1.16. The 5 lowest
energy models are rejected because they have less than 35 class A conserved contacts. Only the 6th
lowest energy model satisfies this criterion.
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θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-773.7 479 -743.4 35 1.75 1.82
-769.8 2356 -743.0 34 1.76 1.70
-771.1 1467 -742.5 33 1.90 1.28
-775.5 186 -741.9 35 1.75 1.71
-776.6 97 -741.5 36 1.66 1.29
-775.6 175 -741.0 39 1.64 1.42
-773.7 490 -740.7 35 1.70 1.10
-771.6 1179 -740.6 37 1.65 1.46
-778.8 26 -740.6 35 1.80 1.25
-773.4 555 -740.1 34 1.83 1.42
. . .
-704.9 33 0.90 0.69
Figure 4.9: Trihelix results for P2Y12 when starting from a hybrid structure of PAR1 helices aligned
to the P2Y12 crystal structure. Same legend as for Fig. 4.6. The starting RMSD is 0.97.
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A2A from β2 AR template
θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-693.6 1643 -670.4 31 2.21 2.04
-701.5 9 -668.9 36 2.00 1.61
-694.8 854 -668.3 35 1.97 1.91
-698.2 87 -668.3 36 2.19 1.92
-697.0 201 -668.1 35 2.00 1.75
-696.5 309 -668.0 29 2.01 1.90
-698.0 107 -667.8 37 2.00 1.38
-695.8 491 -667.7 31 2.26 2.03
-694.1 1289 -667.7 34 1.91 1.89
-697.9 108 -667.7 35 2.18 1.86
. . .
-588.6 30 1.53 1.66
Figure 4.10: Trihelix results for A2A when starting from the homology model based on β2. Same
legend as for Fig. 4.6. The starting RMSD is 1.85. The lowest energy model is rejected because it
has less than 35 class A conserved contacts. The 2nd lowest energy model has 36 contacts, so it is
selected as the solution.
4.5.4 Prediction from Homology Model
Finally, we move to the full prediction of the A2A and P2Y12 helical bundles. First, we study
the Trihelix sampling of the A2A homology model based on the β2 template without using any
information about A2A other than its sequence. Figure 4.10 shows that the starting template has
RMSD 1.86 A˚. The lowest energy model has RMSD 2.21 A˚, but it only has 31 conserved contacts
contacts, so we discard it using the GPCR health heuristic. The second lowest energy structure with
RMSD 2.00 has 36 conserved contacts, so we keep it as the solution. There are conformations with
lower RMSD — for example the conformation with rounded coordinates has 1.53 A˚ — but they are
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Figure 4.11: The predicted A2A structure (green) based on the β2 homology model (grey). The A2A
crystal structure is shown in blue. Residues forming the inter-helical hydrogen bond are displayed
in stick representation.
not low in energy.
The selected structure is shown in Figure 4.11, where we can see that the overall position of TM
1 and 7 improved. On the other hand, TM 2 and 3 undergo a rotation which puts their ends at
an incorrect orientation. Such misalignment accumulates a lot of cost into the RMSD measure. In
this Trihelix run the initial RMSD increased from 1.86 to 2.00, but residues contributing most to
the RMSD are not important for binding. In the next section we point out that the binding pocket
actually improved slightly. Another characteristic in which the structure improved is the number of
hydrogen bonds, which increased from 8 to 11 (there are 15–18 for a typical GPCR crystal structure).
The behavior of polar residues, which can form hydrogen bonds, is important because they cannot
make polar contacts with the membrane environment.
The last Trihelix run we discuss is the prediction of P2Y12 from the PAR1 template. Figure 4.12
shows that the lowest energy structure improved the RMSD from 2.23 A˚to 1.99 A˚. This structure
has 35 conserved inter-helical contacts, which passes the health test. Again, some of the sampled
structures have lower RMSD than this, but they score too high in energy.
Figure 4.13 shows the lowest energy model for P2Y12. TM5 undergoes the most significant
improvement, as it moves about halfway to its correct position. TM 6 improves as well, but it does
not make a large tilt, which would decrease the RMSD even more. The reason this move is not
found is because of the deformed TM6 of the PAR1 template, which has two neighboring small
amino acids, Gly and Pro, while P2Y12 only has Pro. Even without this move, the number of
inter-helical hydrogen bonds increased from 10 in the homology model to 14.
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θ α β z Trihelix Trihelix Energy Number of RMSD RMSD
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts TM (A˚) pocket
-736.9 73 -706.4 35 1.99 2.43
-731.8 626 -705.5 32 2.25 2.64
-741.0 11 -705.4 33 2.37 2.96
-734.1 262 -704.9 35 2.43 2.90
-733.3 343 -704.6 38 2.03 2.58
-739.7 21 -704.6 33 2.20 2.50
-730.5 1075 -704.5 36 2.08 2.64
-732.0 582 -704.3 32 1.94 2.44
-734.7 203 -704.1 35 2.12 2.35
-740.0 19 -704.1 34 2.12 2.56
. . .
-658.9 32 1.58 1.66
Figure 4.12: Trihelix results for P2Y12 when starting from the homology model based on PAR1.
Same legend as for Fig. 4.6. The starting RMSD is 2.23.
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Figure 4.13: The predicted P2Y12 structure (green) based on the PAR1 homology model (grey).
The P2Y12 crystal structure is shown in blue. Residues forming inter-helical hydrogen bond are
displayed in the stick representation.
4.5.5 Binding Pocket RMSD
The most important structural feature for drug discovery is the shape of the binding pocket. Any
improvements of the binding site result in highly improved docking outcomes. Let us define the
binding pocket RMSD as the backbone RMSD of residues which are close (< 5A) to the ligand in
the crystal structure. Figure 4.14 shows the ligand placement in the two studied cases.
For A2A the binding pocket RMSD improved slightly from 1.64 A˚ to 1.61 A˚. However, for P2Y12
there was a significant improvement from 2.82 A˚ to 2.43 A˚. In both cases, the RMSD improvement
in the binding pocket is better than the RMSD improvement of the full transmembrane bundle. This
is because much of the contribution to the RMSD measure comes from the ends of helices that are
most misaligned. If the loops were present, they would constraint the helical ends and the RMSD
would be a more suitable measure.
4.6 Discussion
The Trihelix method improves the RMSD of a homology model for P2Y12 from 2.23 A˚ to 1.99
A˚. The same method does not improve the RMSD of a homology model for A2A, as the RMSD
increased from 1.86A˚ to 2.00A˚. This suggests that the transmembrane bundle similarity below 2 A˚
is very good and is difficult to refine without the prior knowledge of the correct helical shapes.
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(a) Orientation of the high-affinity subtype-selective
antagonist ZM241385 in the A2A binding pocket
[36].
(b) Orientation of the reversible antagonist
AZD1283 in the P2Y12 binding pocket [47].
Figure 4.14: Improvements in the binding pocket.
As we suggested, the RMSD of the TM bundle may not be the best measure to compare the
performance of the structure refinement. In both cases, the RMSD of the binding pocket decreased:
for P2Y12 significantly from 2.82 A˚ to 2.43A˚, and for A2A slightly from 1.64 A˚ to 1.61 A˚.
The TM5 of the P2Y12 model moves approximately halfway from the starting position to the
desired crystal position (shown in Fig. 4.13). This suggests that we should consider either increasing
the grid size to allow large moves or increasing the number of grid points. Increasing the grid size
makes impossible minor adjustments of helical positions so that the neighboring helices fit together.
On the other hand, increasing the number of grid points creates too many conformations at the early
stages of the protocol. When there are too many conformations, the errors in the Bihelix mean field
energy cause selection of incorrect low energy conformations.
There is a fine balance between the coordinate grid steps and resolution of the energy function.
Increasing the step size makes the crystal structure reconstruction more robust, but it makes it less
likely to capture a good structure when making a refinement from a homology model. Decreasing
the step size overwhelms the resolution of the energy function, resulting in an inability to select the
correct structure. In fact, the all-zero conformation in the P2Y12 crystal structure reconstruction
(Fig. 4.5) is not the lowest energy one. Decreasing the step size further would only make this worse.
In comparison to Monte Carlo protein refinement, the Trihelix energy vs. RMSD plot is not a
funnel plot because only a few structures near the target are sampled. This makes it harder to test
whether a good structure has been found. The energy gap separating the lowest energy model is
not very high in most of the runs. Instead of relying solely on the energy function to select the
solution, we use a GPCR health heuristic, which only keeps the models with 35 or more conserved
inter-helical contacts.
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The structure refinement starts from a homology model with approximate helix shapes and
approximate helix orientations. From the two approximations, the helix shapes are more important
for being able to select the correct structures using the energy function (Section 4.5.3). This is
because the homology helix orientations are consistent with each other, but the homology helix
shapes do not have to be consistent with the sequence. In particular, Pro and Gly residues cause
kinks and irregular turns, which can cause large clashes with the nearby helices in the homology
models. Any clashes at the Bihelix stage are problematic, since the conformation with clashes are
removed from further considerations.
In the present work, we ignore the role of the loops. Since the loops are missing, minimization
sometimes moves the helices apart to avoid clashes. To prevent this breakdown of the helical bundle
during minimization we add small constraints on the backbone positions. The strength of the
constraints is tuned to avoid the unwanted large moves, while allowing some flexibility of the helices.
4.7 Conclusion
It remains a challenge to refine the homology models below 2 A˚ because the helix shapes are unknown.
The helices have to be consistent with each other, similar to a lock and a key. A similar situation
occurs in other computational problems involving proteins, such as docking: if the correct protein
backbone and the correct ligand conformation are known, the docking algorithms can often reliably
find the binding site and recover the side-chains. However, if the correct backbone conformation or
the correct ligand conformation is not known, the problem becomes much more difficult.
One way to significantly improve the effectivity of the structure refinement is to make sure there
are no misaligned prolines. In some cases, this can be achieved by combining more templates with
each other depending on the sequence of the studied protein.
We developed and characterized Trihelix, a new method for GPCR structure refinement. This
method uses mean field approximations to completely sample a large number of coarse degrees
of freedom. We have successfully demonstrated a refinement of the P2Y12 homology model and
explored the limits of validity of the method. In the next chapter, we apply this method to predict
the lactate receptor structure.
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Chapter 5
Structure Prediction of the Lactate
Receptor HCAR1
5.1 Receptor Family and Expression in Cancer
In this chapter we apply the Trihelix sampling method to model the TM bundle of the hydroxy-
carboxylic acid receptor 1 (HCAR1, also lactate receptor). We complete the extracellular part of
the model by generating and refining many possible loop conformations. Modeling of moderately
long loops is made possible by constraints coming from three expected disulfide bonds. Finally,
we dock the lactate molecule and a new higher affinity ligand to study possible binding sites. We
propose a binding site which agrees with the available mutation data and thus provides a validation
of the receptor model. A high accuracy model is needed to search for new antagonists that block
the receptor activation.
Interest in the HCAR1 receptor is rising because it is expressed in many types of cancer. A recent
study [83] shows that the lactate receptor HCAR1 is expressed at high levels in 95% of pancreatic
cancer patients, and that its expression levels correlate with cancer growth and metastasis. Silencing
the HCAR1 expression leads to a dramatic decrease in the tumor growth. The receptor is important
for cancer survival in the low oxygen, high lactate microenvironment of tumors. A small molecule
antagonist could block this receptor and slow down cancer growth.
Endogenous Ligand Structure HCAR1 HCAR2 HCAR3 Reference
2-hydroxy-propanoate (lactate) 1500, 3000 Inactive Inactive [84, 85]
3-hydroxy-butyrate Inactive 770 >25,000 [86]
3-hydroxy-octanoate Inactive Inactive 8 [87]
Table 5.1: Structures of endogenous hydroxy-carboxylic acids acting on HCAR1, HCAR2, and
HCAR3. Half maximal effective concentration values (EC50, in µM) are determined from a down-
stream signaling pathway. Source [88].
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(a) HCA1 (b) HCA2 and HCA3
Figure 5.1: Functions of HCA1, HCA2, and HCA3. (a) The lactate receptor HCA1 mediates the
short-term anabolic effects of insulin on adipocytes and thereby helps store energy after feeding.
(b) HCA2 and HCA3 receptors are involved in the long-term regulation of lipolytic activity. In
situations of increased β-oxidation rates (e.g., during starvation), 3-hydroxy-butyrate and 3-hydroxy-
octanoate plasma levels are increased and result in the inhibitory regulation of lipolysis via HCA2
and HCA3 receptors, respectively, in the form of a negative feedback loop. Therefore, HCA2 and
HCA3 receptors help preserve energy stores during starvation. Source: [91]. AC, adenylyl cyclase;
TG, triglycerides; HSL, hormone-sensitive lipase; ATGL, adipocyte triglyceride lipase; FFA, free
fatty acids; PKA, cAMP-regulated protein kinase.
The lactate receptor is part of the hydroxy-carboxylic acid receptor family, whose endogenous
ligands are intermediates of energy metabolism [88, 89, 90, 91]. These ligands (shown in Table 5.1)
are small hydroxy-carboxylic acid compounds, which are very similar to each other, yet the receptors
are specific to their respective endogenous ligands. The high specificity of these receptors to the
set of similar molecules suggests that a high accuracy model is needed if we want to find new drug
candidates.
Besides its involvement in cancer, the lactate receptor could be a direct drug target for dyslipi-
demia. At present, nicotinic acid, which targets HCAR2, serves as a dyslipidemic drug. However,
besides fat tissues, HCAR2 is also expressed in skin, and so the nicotinic acid often has a serious
side effect of flushing (redness). An agonist biding to HCAR1 could treat dyslipidemia without the
side-effects, because HCAR1 is mostly expressed in fat tissue. The differences in function of these
receptors are outlined in Figure 5.1. In particular, HCAR1 helps store energy after feeding, and
HCA2 and HCA3 help save energy during starvation.
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θ α β z Trihelix Trihelix Energy Number of
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts
-691.7 33
. . .
-700.0 1989 -690.3 31
-700.4 1752 -687.9 31
-702.0 904 -686.8 32
-703.3 506 -686.7 32
-705.6 177 -686.5 29
-707.4 65 -685.9 31
-699.8 2200 -685.4 32
-704.8 265 -684.3 29
-711.9 1 -684.3 30
(a) Trihelix sampling of HCAR1 starting from the P2Y12 template fails to find a good candidate structure.
The all-zero structure was dropped at the bi-helix and Trihelix stages, but it actually has a lower energy
than the lowest energy Trihelix prediction. Furthermore, the sampled structures have 32 or less contacts
from the conserved contacts list of 40 contacts, which indicates that the sampled structures do not approach
the GPCR fold.
θ α β z Trihelix Trihelix Energy Number of
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 energy rank (REU) contacts
-717.8 227 -698.2 37
-713.2 1656 -697.4 33
-716.0 515 -696.7 35
-723.1 9 -696.7 33
-718.1 198 -696.6 34
-713.0 1885 -696.3 31
-719.5 91 -696.2 37
-715.2 722 -696.1 34
-720.3 58 -696.0 35
-714.9 799 -695.7 34
. . .
-606.4 37
(b) Trihelix sampling of HCAR1 starting from the PAR1 template finds a good candidate structure, which has
a lower energy than the starting all-zero structure. The solved structure is shown in Figure 5.3. Furthermore,
37 (out of 40) class A conserved contacts are present in this structure, which indicates a high quality model.
Compared to the models derived from the P2Y12 template, this time the z coordinate is 0 for all the low
energy conformations.
Figure 5.2: Trihelix results for HCAR1.
5.2 Trihelix Sampling of HCAR1
We now move on to the prediction of the HCAR1 structure, which is in the Aδ subclass. The only
available crystal structures in Aδ subclass are P2Y12 and PAR1, which we both use as templates. We
use the transmembrane region alignment from Chapter 3, in which HCAR1 has a very low sequence
identity of 24% and 29% with P2Y12 and PAR1, respectively. The TM sequence similarity to these
templates is 47% and 48%. The similarity is close to the cases used to benchmark the Trihelix
sampling, therefore, we apply the Trihelix sampling with the same size of steps as developed and
benchmarked in Chapter 4: TM rotation around axis θ = −15°, 0°,+15°, TM tilts α, β = −7°, 0°,+7°,
and TM translations along axis z = −2A, 0A, 2A. The lowest energy structures from the sampling
are listed in Figure 5.2.
The lowest energy structures based on the P2Y12 template have higher energy than the starting
structure. This indicates that the suitable TM coordinates were dropped at the bi-helix and tri-
helix mean-field approximations. The mean field energies are computed from structures with two
and three helices only, so it is possible to get incorrect side-chain positions from the the side-chain
placement algorithm. Another warning signal is that the number of conserved contacts is 32 or lower
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Figure 5.3: The HCAR1 model (green) is the lowest energy structure from the Trihelix run based
on the PAR1 template (grey). The residues which form inter-helical hydrogen bonds are displayed
in stick representation. The number of inter-helical hydrogen bonds increases from 10 in the all-zero
structure to 14 (GPCR crystal structures have typically 15-20 inter-helical hydrogen bonds).
(out of 40) for all 10 lowest energy models, so the sampling is probably stuck in some local energy
minimum not close to the GPCR fold. Therefore we disregard this particular run.
The results based on the PAR1 template are more reasonable. First, all sampled low energy
models have lower energy than the starting structure, therefore the sampling actually decreased the
energy of the template. Second, the lowest energy structure has 37 inter-helical contacts common
with class A, and so this model is close to the GPCR fold. We take the lowest energy structure to
be the model for the HCAR1 TM bundle. It has energy -698.2 REU (Fig. 5.2b), which is lower than
energy of any models based on the P2Y12 template. The most notable difference between the two
runs is that the PAR1 template kept all TM with z = 0.
The solved model is shown in Figure 5.3. The largest changes from the template are in the TM
5 and 6 movement, with smaller adjustments of TM 4 and 7. These changes allow for 14 inter-
helical hydrogen bonds, compared to 10 in the starting structure. Sometimes the helical bundle
without loops is used for ligand binding studies, but since lactate is a small molecule, we build the
extra-cellular loop bundle before docking.
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Loop Residues Length Cysteines
N-terminus (1) 3-14 12 6, 7
EC1 77-84 8
EC2 153-170 18 157, 165
EC3 245-253 9 252
Table 5.2: Extra-cellular loop lengths
5.3 HCAR1 Extracellular Loops
To complete the extracellular part of the HCAR1 model, we need to build the three extra-cellular
loops and the N-terminus. Their lengths are listed in Table 5.2. The EC2 loop is the longest at 18
residues, which is challenging for the common loop building approaches.
Let us briefly discuss the performance of several GPCR loop prediction methods. If the protein,
nearby loops, and side-chains are at exactly the same positions as in the crystal, even long loops
over 20 amino acids can often be reconstructed to RMSD <2 A˚ [92]. However, when the side-chains
are not from the crystal structure but are predicted, the accuracy of the loop prediction decreases
rapidly. Nikiforovich et al. [93] managed to solve short loops (8 -10 residues) to RMSD 3-5 A˚, and
long loops (>=25 residues) only to RMSD > 7 A˚. GPCR loops are expected to be very flexible and
it is not clear whether the low accuracy is due to inherent flexibility of the loops, or due to lack of
sampling and an approximate energy model.
General loop prediction methods are benchmarked on stable, high resolution crystal structures.
Stein et al. [94] implemented a robotics-inspired conformational sampling within the Rosetta frame-
work, which solves many 12 residue loops to sub-angstrom accuracy. Even for this loop length, there
are cases which cannot be solved to RMSD below 6 A˚. The fraction of loops which can be solved
drops down for loops 14 and 15 residues long, and no 17 residue loops are solved successfully.
Fortunately, in the case of HCAR1, the situation simplifies due to the presence of disulfide bonds,
which can be used as constraints. From mutation studies, Kuei et al. [95] suggested that disulfide
bonds are formed between the following cysteine pairs:
Connectivity A: Cys 88 (TM3) - Cys 165 (EC2)
Cys 6 (Nterm) - Cys 252 (EC3)
Cys 7 (Nterm) - Cys 157 (EC2)
The cysteines C88 and C165 are highly conserved in class A and the disulfide bond between them
is present in all the crystal structures in which these cysteines are present. The mutation of any of
these two cysteines stops cell surface expression of the protein, so this disulfide bond is important
for the folding of HCAR1 in the membrane. Mutation of the other 4 cysteines allows the protein
to assemble in the membrane, but it is not sensitive to its endogenous ligand. Since C6 and C7 are
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close together, we consider also an alternative connectivity:
Connectivity B: Cys 88 (TM3) - Cys 165 (EC2)
Cys 7 (Nterm) - Cys 252 (EC3)
Cys 6 (Nterm) - Cys 157 (EC2)
We programmed a loop building algorithm, which builds random loop bundles consistent with the
known disulfide constraints. This algorithm builds all loops at once, residue-by-residue, by randomly
sampling backbone torsions from the selected Ramachandran distribution. From each anchor point
(TM end) we grow N = 10, 000 loop candidates, so that there are many possible combinations
for loops closure. From the N2 possibilities for each loop closure, we choose the ones which have
best geometrically correct bond. As each residue is added we check if the following constraints are
satisfied, otherwise we generate a new random trial:
• given the number of remaining residues, each loop can close
• given the number of remaining residues, each disulfide can be formed
• each loop avoids clashes with TM and the membrane region
• each loop avoids clashes with itself
We build 1000 random loop bundles and then refine each one using Rosetta’s kinematic loop builder
[94]. Since the refinement is a random algorithm as well, we keep 6 candidates from each loop
refinement. We use the Rosetta energy function to select the low energy models.
Interestingly, among the low energy models, the EC2 loop appears in two different topologies. In
the first case (Fig. 5.4a), the EC2A part of the loop is positioned under the EC2B part. However,
this is not consistent with the disulfide C88-C165 forming early during the protein assembly from
the individual helices in the membrane. The second case (Fig. 5.4b), is consistent with the TM
assembly as the C88-C165 forms first and C6-C252 (or C7-C252) form later. After removing the
loop bundles with the wrong topology, we keep the 23 low energy bundles for the docking studies
(shown in Fig. 5.5). In the current energy model, we do not see a preference for either the disulfide
connectivity A or B, so we choose 10 lowest energy conformations from each and add an additional
3 conformations with interesting conformation of His 155 in EC2.
5.4 Lactate Docking to the HCAR1 Model
In this section, we study the possible binding site of lactate, which is the endogenous ligand for
HCAR1. Compared to other GPCRs, a very high concentration of lactate is necessary to activate
this receptor (> 1mM), because lactate is an intermediate of energy metabolism and is present at
59
(a) Rejected EC2 topology (b) Possible EC2 topology
Figure 5.4: The highly conserved disulfide bond Cys 88 (TM3) - Cys 165 (EC2) is critical for
assembly of the protein in the membrane. Likely, it forms first before the other two disulfide bonds
during the protein folding process, so the EC2B segment has to be under the EC2A segment (from
an extracellular view point).
Figure 5.5: The ensemble of 20 lowest energy extracellular loop bundles. An additional 3 bundles
with interesting conformation of HIS155 in EC2 were added. The disulfide bonds are partially visible
(yellow). Even though the loops are constrained by three disulfide bonds, they can still fold in many
different ways.
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high concentrations. In addition, lactate is a very small molecule and it can fit into the binding
pocket in many different orientations. This is a challenge since only a finite number of cases are
considered by the docking algorithm. Therefore, we start with docking 3,5-dihydroxybenzoic acid
(DHBA), which is a recently discovered agonist specific to HCAR1 [96]. Not only is DHBA a larger
molecule, but only a 10× lower concentration is required to activate the receptor (150µM).
We follow the docking procedure reported in [97]. To compare the ligand poses we use the neutral
snap binding energy, defined as the difference between the energy of the complex and the energy
of the protein and the ligand evaluated in the Dreiding force field [77]. Bray et al. [98] showed
that evaluating energy after neutralization gives better correlation of the binding energy to the
experimental binding affinity than interaction energies between charged groups. Here neutralization
means proton transfer between nearby charged groups, which maximizes the number of hydrogen
bonds.
For each of the 23 candidate loop bundles, we dock DHBA into the binding site between the TMs
2, 3, 6, and 7. This produces about 2300 candidate poses. To reduce the number of poses, we use
constraints coming from an analogy to the biogenic amine receptors. In biogenic amine receptors
Asp 3.36 always binds with the N+ atom in the ligand. Furthermore, this Asp or the ligand interacts
with the nearby Tyr 7.43. In HCAR1, there is Arg 99 (3.36), which has no negative charge group
nearby, so we expect it to bind with the negatively charged ligand. Also, Tys 268 (7.43) is conserved
in this protein and in constructed models without a ligand it always interacts with Arg 99. Thus we
keep only 100 poses, which minimize the sum of two distances:
• carboxyl group of the ligand to the guanidinium group of Arg 99
• OH group of Tyr 268 to the guanidinium group of Arg 99
After reducing the number of poses to 100, we annealed the ligand and side-chains within 5A˚, and
evaluated the neutral snap binding energies. Figure 5.6a shows the best scoring pose. The carboxyl
group of the ligand interacts with Arg 99 and Arg 240, which is neutralized by Glu 166. One of
the hydroxy groups on the ligand interacts with Arg 71 and Tyr 268. We see that there are a large
number of charged interactions.
We repeated the same procedure for lactate. Lactate is a smaller molecule, therefore its position
and orientation in the low energy poses varies more across the TM 2-3-6-7 pocket. The 8th lowest
energy pose (Fig. 5.6b) shows very similar interactions as the DHBA pose. Since DHBA is a larger
molecule than lactate, and a lower concentration is necessary to activate HCAR1, the docking results
for DHBA are more reliable. Thus we select the 8th lactate pose. Both ligands bind in a similar
area of the TM 2-3-5-6 pocket, and directly bind to residue Arg 71, Arg 99, Arg 240, and Tyr 268.
This binding mode is similar to the binding site suggested by Kuei et al. [95], except the study
did not find any interaction with Tyr 268 and instead assumed direct ligand interaction with the
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Figure 5.6: Predicted binding sites for the two ligands (purple). Hydrogen bonds between the ligand
and nearby residues are shown in yellow.
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nearby Glu 166. The mutation study shows (also [85]) that alanization of any of the following
residues stops the receptor sensitivity to the lactic acid:
• Arg 71, Arg 99, Arg 240, Glu 166, Tyr 233, Thr 267
Our docking shows that the three arginines likely directly interact with the ligand. Glu 166 seems to
control the charge environment near Arg 240, and Tyr 233 and Thr 267 are important for changing
the receptor conformation to the active one.
5.4.1 Possible Binding in TM 3-5-6 Pocket
Since a mM concentration of lactate is required to activate the receptor and lactate is a small
molecule, it is possible that two lactate molecules need to bind for the receptor activation. Here
we explore this possibility. The HCAR1 binding pocket is tightly covered by the extracellular loop
bundle, which includes the N-terminus. The largest opening is near TM2 and TM7, where there are
also a large number of arginines. It is possible that the Arg 71 on TM2 only acts as an intermediate
charge partner to a lactate molecule as it enters the binding pocket and moves deeper between TM3,
5 and 6. We repeated the docking procedure for this biding pocket.
For lactate, many possible poses were found in which the carboxyl group interacts with Arg71
and Arg240 (both or one of them). The snap binding energies were similar to docking in the 2-3-6-7-
pocket. However, DHBA docking is more conclusive, as the best snap binding energy in this site
(-42.1 kcal/mol) is lower than in the 2-3-6-7- pocket. It is not likely that DHBA binds between
TM3-5-6 and thus it is not likely that lactate binds there either.
5.5 Conclusion
We applied the Trihelix sampling method to build a model for the HCAR1 receptor. To model its
extracellular loops, we implemented a novel loop building method which uses constraints from known
disulfide bonds. Since the GPCR loops are expected to be flexible, we generated many candidate
loop conformations.
In order to find a binding site for lactate, which is a very small molecule, we first performed
docking of 3,5-dihydroxybenzoic acid, a larger molecule with similar hydroxy-carboxylic motive.
The identified binding site is in agreement with the available mutation data. The ligand binding
involves many charged residues. Three arginines interact directly with the ligand, and the binding
pose is stabilized by a nearby glutamic acid. The successful ligand docking validates the quality of





Force fields allow atomistic modeling of systems with more than 100 000 atoms, which is required
for the modeling of proteins and surrounding solvent. The accuracy of force fields is key to realistic
simulations. Molecular dynamics simulations most often use AMBER [78] and CHARMM [99] force
fields, which parametrize the forces between atoms with several bonded and non-bonded terms.
Bonded terms — bond, angle, and dihedral — capture the effect of covalent bonds. Non-bonded
terms capture the electrostatic force and van der Waals interaction (both the short distance repulsion
and the long distance attractive forces). In this work, we have mostly used the Rosetta force field,
which includes several other empirical energy terms that were computed statistically from analysis
of the database of known crystal structures. Rosetta treats the electrostatic interaction similarly
to the other force fields. Accurate charge assignment is essential to determining the electrostatic
energies in molecular dynamics simulations.
Although the electron density in molecules is diffuse, the short distance effects are included in the
bonded terms, so the electrostatic force can be computed as interaction of point charges placed at the
atomic nucleus. In this chapter we describe a method that allows one to assign the atomic charges
to an arbitrary molecular system. The new method extends the successful QEQ charge equilibration
method to include atomic polarization, which is a property ignored by many of the point charge
models. The polarizable QEQ method has, therefore, the potential to describe qualitatively new
types of phenomena.
6.2 Charge Equilibration Based On Electronegativity
Many commonly used methods derive charges from density functional calculations and fix the charges
throughout molecular dynamics (MD) simulations [100, 101, 102]. Fixed charges cannot adjust to
their local electrostatic environment. Reactive force fields [103, 104, 105, 106, 107], on the other
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hand, change connectivity during the MD runs and thus require updates of assigned atomic charges.
The charge equilibration (QEQ) scheme proposed by Rappe and Goddard [108] has been highly
successful in determining geometry dependent charges that respond to changes in their environment.
One advantage of this method is that it is minimally parameterized, utilizing experimental ionization
potentials, electron affinities, and atomic radii. In order to model polarizable materials Zhang et
al. [109, 110] proposed an extension of QEQ, which uses Gaussian charges and allows for charge
polarization (PQEQ). This framework enables the assignment of atomic charges independently of
atomic bonding and takes the local electrostatic environment into account. The PQEQ framework
enables a description of polarized systems by allowing the position of the electron cloud to become
displaced from the atomic nucleus.
In [7] we performed a constrained optimization of the QEQ atomic parameters of the elements
of the first three rows of the periodic table (except for noble gases) to work well with the Gaussian
charge distributions, while maintaining periodic trends and the original physical motivation. In the
following sections we derive the expressions that were used for programming the PQEQ method
into the LAMMPS molecular dynamics package [111]. A particularly useful feature for biological
simulations is the speed at which new systems can be parametrized. For example, charges for
thousands of drug candidates can be computed on the fly in virtual ligand screening. Another
advantage of PQEQ is that the computation of charges is fast even for large systems such as proteins.
6.3 Polarizable QEQ with Gaussian Charges
The QEQ [108] method is a charge equilibration scheme based on minimizing the total electrostatic
















Here Cij(rij) is the screened Coulomb interaction between atom i and j. Parameters χi and Ji are
electronegativity and idempotential of the atom i and they can be related to ionization potential

















= IP − EA = idempotential
The atomic charges qi are chosen such that they minimize the total energy, E, subject to the
constraint that the sum of the charges is fixed (or that the total charge on each molecule is fixed [112]).
In the original QEQ method, the screened Coulomb interaction Cij is computed as the elec-
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trostatic interaction of two Slater-type orbitals. In order to be able to model atomic polarization,
Zhang et al. [109, 110] developed polarizable version of QEQ (PQEQ), in which each atom has a
charged core with a fixed charge qic and a variable shell charge qis. The charges were modeled with











, where Rik is the atomic radius. The electrostatic energy between two Gaussian charges





















In PQEQ, to prevent the shell from drifting away from the nucleus, the shell is attached to the core






















C(ricjc)qicqjc + C(risjs)qisqjs + C(ricjs)qicqjs + C(risjc)qisqjc
)
.
Most of the contribution to the total electrostatic energy comes from near neighbor interactions,
so we do not expect that the difference between the tail of Slater and Gaussian functions to cause
a large error. Nevertheless, the parameters of the original QEQ were shown to produce charges
with a large mean squared error and therefore must be optimized to work with Gaussian functions
[7]. After parameter optimization, the Gaussian QEQ produces the desired point charges while also
enabling description new phenomena, such as polarization.
6.4 Solving for Charges Using Pseudo-Dynamics
When computing charges, minimizing the total electrostatic energy (Equation 6.1) with respect to
the charges ( ∂E∂qi = 0) and charge conservation (
∑
qi = Qtotal) leads to a system of N + 1 linear
equations. The exact solution by matrix inversion is expensive and scales as O(N3). This approach
is used by the current implementation of QEQ [113] in the MD simulation package LAMMPS [111].
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Since the charges are changing slowly during the MD run, in practice only M iterations are needed
every time step to obtain converged values, decreasing the scaling close to O(MN). An alternative
approach, pioneered by Rick et al. [112], is to evolve the charges according to an equation of motion
with damping, which has linear scaling O(N). We implemented this fast method.
To evolve the charge variables dynamically, we assign virtual mass mQ to the charges qi, and
solve the corresponding equation of motion:
mQq¨i = FQ,i − γQq˙i + λ (6.2)




(FQ,i − γQq˙i) (6.3)
where the generalized force is FQ,i = − ∂E∂qi and λ is the Lagrange multiplier enforcing charge con-
servation. In to the equation of motion ∂E∂qi = 0, we added the attenuation force FQ,friction = −γQq˙i,
so that the dynamics minimizes the total energy.
The value of the virtual mass mQ must be chosen carefully. Smaller values of mQ lead to larger
changes in atomic charges each timestep. For mQ too small the numerical integration will become
unstable. For large mQ the charges will converge slowly. For fastest convergence, mQ and γQ should
be set to critically damp the system. This method of solving the system of N linear equations scales
as O(N) and thus scales well to large systems.
The side effect of solving the charges with damped dynamics is that the charges lag behind the
values which would be obtained by exact minimization of the electrostatic energy. With a proper
choice of the damping constant, this effect can keep charges approximately constant during bond
vibrations. Averaging the charges over bond vibrations is preferable to letting the charges fluctuate
nonphysically during bond vibrations.
6.5 Charge Convergence
Instead of mQ and γQ we would like to input a parameter controlling the damping time τ and the
damping ratio ζ. One can express the QEQ equation of motion (Equation 6.2) in the form of a
damped harmonic oscillator:
x¨+ 2ζωx˙+ ω2x = 0,
where ζ is the damping ratio and ζ = 1 corresponds to critical damping. The solution of the critically
damped harmonic oscillator is (A+Bt)e−ωt. Let’s say that the initial condition was x(0) = A and
x˙(0) = 0; then the solution writes A(1 +ωt)e−ωt. This attenuates to 1/e when ωt ≈ 2.15, so we can
express ω = 2.15/τ in terms of the damping time τ .
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Figure 6.1: QEq pseudodynamics convergence: A cyclohexane molecule has fixed geometry and only
the charges dynamics are run. Charges are plotted for a carbon C1 and its two bonded hydrogens
H7 and H8. The charges for three values of ζ are plotted: solid line ζ = 0.6 (underdamped), dashed
line ζ = 1 (critically damped), and dotted line ζ = 2 (overdamped). τ = 15fs.
Comparing the canonical damped harmonic oscillator to the QEQ equation of motion yields:
γQ/mQ = 2ζω = 4.30ζ/τ
1/mQ ∼ ω2 ∼ 1/τ2
where mQ is in mass units. From a test run we approximated mQ ≈ (τ/11.3)2, where τ is in fs and
mQ in grams/mole (‘real’ units in LAMMPS). Now we can express the parameters controlling the




For dynamics, we expect to use values τ = 30fs and ζ = 1. When atomic coordinates are fixed and
only charges are solved for, values τ = 15fs and ζ = 0.6 give good convergence in about 100 steps.
By setting the time constant of the QEQ dynamics longer than a bond vibration period we can
smooth the charge value assigned to each atom during a molecular dynamics run. As an example
of the charge pseudynamics we choose a cyclohexane molecule and set τ = 15fs. Figure 6.1 shows
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Figure 6.2: Molecular dynamics of a single cyclohexane molecule with atomic velocities corresponding
to 300 K. For a large time constant τ = 15fs (solid line) the charges are averaged over the period
of a bond vibration, but for a short time constant τ = 1.5fs (dotted line) the charges adjust as the
bond length changes during bond vibrations. The damping ratio is set to critical damping ζ = 1.
the evolution of charges during the initial run when charges are allowed to change, but the atomic
geometry is fixed. Within 40 fs (40 steps), the error on all of the charges is less than 0.05 from the
exact solution, and in 100 fs the error is less than 0.01.
After initialization of the charges, we assign random velocities to the atoms corresponding to 300
K and let the atomic positions evolve along with the atomic charges. Bonded and VDW parameters
are from the Amber99 force field [78]. Figure 6.2 shows that the damping parameters keep the
charges approximately constant during bond vibrations.
6.6 Optimization of Shell Positions Using Newton-Raphson
So far we described how to solve for the charges using dynamics in the charge degree of freedom.
In PQEQ, we also need to determine the shell positions. One could split the atomic mass between
the shell and core and evolve this degree of freedom as well. However, the potential confining shells
near each core is spherically symmetric and approximately harmonic, and so we can find the optimal
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position of shells ris using the Newton-Raphson method. In each MD step we run one iteration of
the Newton-Raphson method, and since the charges need at least 10 steps for convergence this is
enough for convergence of the shell positions as well.
To get the second derivative we neglect the effect of the remote charges, so we do not need to
invert the Hessian. If the force FRS,i, position of the core ri,c, and position of the shell lie on a line,
we can estimate the new position of the shell as:
FRS,i = − ∂E
∂xis

















qicqis + 2K2 + 12K4x
2
is.
The problem is not one-dimensional, but we can keep the above second derivative, and for each shell
rotate into the direction in which the force acts.
6.7 Ewald Summation for Periodic Systems









|ri − rj + R| , (6.4)
where
∑
R is the sum over primitive cells of the system (R = 0 is excluded when i = j). The 1/r
potential is long ranged so a large number of particles have to be included in the sum. The sum 6.4
can be converted into a k-space sum [114], in which case there is a problem with convergence for
small K, caused by the Fourier transform of the point charge (delta function). If the point charges
are replaced by charge distributions, the sum in the k-space converges.







and summed the total energy in k-space. The energy coming from the difference in the point charges
and the Gaussian charge converges quickly in real space. In order to stay close to the current
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implementation of Ewald summation in LAMMPS, we apply an analogous technique to PQEQ. We
replace each Gaussian charge of width αi with a Gaussian charge of width αE and sum the energy
in k-space; the difference of the charge distributions is summed in real space.




















αij |rij + R|),


















summed in k space
Thus we can split the total energy sum into two parts E = Ereal space + Ek space. The first sum can






























































































































This expression converges rapidly due to K2 in the exponential and in the denumerator, thus the
summation can be terminated after a small number of terms. The derivation of Ewald summation
for Gaussian charges followed the Ewald summation for point charges, and so implementation in a
molecular dynamics code can follow the implementation of the usual Ewald method.
6.8 Conclusion
We extended the QEQ charge equilibration method to include the description of the atomic polar-
ization and implemented it in Lammps. Optimization of atomic parameters for the first eighteen
elements of the periodic table is presented in [7]. In the context of biological simulations it is useful
for virtual ligand screening, where appropriate ligand charges can be derived on the fly for any
organic molecule. Furthermore, this method includes the screening effect of the nearby atoms. For
example, charges of an amino acid side-chain adjust depending on if the side-chain is exposed to the
solvent or if it is buried in a hydrophobic environment. The PQEQ method is a step towards the






Figure A.1: Twenty one amino acids. Amino acids connect by peptide bond -CO-NH- and form
long chains, proteins. Image from [116].
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Appendix B
Comparison of GPCR Crystal
Structures
Protein TM1 TM2 TM3 TM4 TM5 TM6 TM7
RHO P34-Q64 (N55) P71-H100 (D83) G106-C140 (R135) E150-L172 (W161) N200-V230 (P215) A241-F276 (P267) I286-M309 (P303)
RHOact P34-Q64 (N55) P71-H100 (D83) G106-C140 (R135) E150-L172 (W161) N200-A235 (P215) A241-T277 (P267) I286-M308 (P303)
Beta1AR W40-S68 (N59) L75-R104 (D87) S111-T144 (R139) R155-M179 (W166) R205-E236 (P219) E285-F315 (P305) D322-C344 (P340)
Beta2AR V31-K60 (N51) V67-M96 (D79) N103-T136 (R131) K147-M171 (W158) Q197-Q229 (P211) K267-I298 (P288) K305-C327 (P323)
Beta2ARact V31-K60 (N51) V67-T96 (D79) F104-T136 (R131) K147-M171 (W158) Q197-S236 (P211) L266-I298 (P288) K305-C327 (P323)
D3 Y32-K56 (N47) T63-V91 (D75) R100-V133 (R128) C147-F170 (W158) P186-K216 (P200) L322-T353 (P344) P362-F386 (P380)
H1 P29-S54 (N45) G62-L89 (D73) G96-Q130 (R125) K141-L163 (W152) T188-A216 (P202) N408-C441 (P430) H448-C471 (P465)
M2 V23-V50 (N41) V57-V85 (D69) P93-T126 (R121) T137-V166 (W148) A184-S213 (P198) K384-F412 (P402) N419-C443 (P437)
M2act F21-V50 (N41) V57-I86 (D69) P93-T126 (R121) T137-V166 (W148) A184-S213 (P198) R381-F412 (P402) N419-L442 (P437)
M3 W65-V94 (N85) V101-M130 (D113) N137-T170 (R165) T181-V210 (W192) P228-E256 (P242) L492-F515 (P505) K522-C546 (P540)
5HT1B L46-R76 (N67) P83-T112 (D95) Q119-T152 (R147) P163-F185 (W174) I206-R238 (P220) K311-P338 (P329) L348-S372 (P366)
5HT2B L54-L81 (N72) T89-M116 (D100) V126-K158 (R153) Q165-K193 (W180) K211-K247 (P229) T315-L349 (P339) Q355-L382 (P377)
A2A S7-L33 (N24) T41-S67 (D52) C74-I106 (R102) G118-L141 (W129) M174-A204 (P189) S223-F258 (P248) L267-R291 (P285)
A2Aact G5-L33 (N24) V40-S67 (D52) C74-R107 (R102) G118-L141 (W129) M174-A204 (P189) S223-F258 (P248) L267-Y290 (P285)
S1P1 E42-K72 (N63) P79-L104 (D91) P114-M146 (R142) F158-I179 (W168) K200-T230 (L213) S249-V280 (P271) A293-T314 (P308)
NTS1act I61-L89 (N82) Q99-I129 (D113) D139-C172 (R167) T186-T207 (W194) T231-T265 (P249) A302-C332 (P323) T341-S373 (P366)
CXCR4 N37-Y65 (N56) M72-V99 (D84) N106-V139 (R134) Q145-F174 (W161) D193-K225 (P211) G231-L266 (P254) C274-Y302 (P299)
CCR5 K26-N57 (N48) M64-A91 (D76) N98-V131 (R126) V142-I165 (W153) Y187-L222 (P206) R230-T259 (P250) C269-V300 (P294)
KappaOR P56-R86 (N77) A93-M121 (D105) G127-A159 (R156) R170-L196 (W183) Y219-L259 (P238) R267-L299 (P289) L309-L333 (P327)
MuOR V66-R95 (N86) A102-M130 (D114) I138-C170 (R165) P181-M205 (W192) T225-R258 (P244) R273-L305 (P295) T312-L339 (P333)
NOP L48-L77 (N69) A85-L113 (D97) G119-C153 (R148) S164-M188 (W175) Q208-L242 (P227) R252-G287 (P278) E295-L322 (P316)
DeltaOR S42-R76 (N67) A83-M111 (D95) E118-C151 (R146) P162-M186 (W173) S206-L238 (P225) R258-L286 (P276) P294-L321 (P315)
PAR1 W100-M131 (N120) P136-F163 (D148) S172-V205 (R200) L216-L239 (W227) G265-L297 (P282) R305-S338 (P328) E347-A374 (P368)
P2Y12 Y21-F51 (N43) N58-A85 (D70) R93-T127 (R122) L138-I161 (W149) E181-R222 (N201) N235-T260 (P251) C270-L301 (P295)
CRF1 Y116-R143 (L134) L150-T175 (F162) G186-V218 (L213) R225-Y252 (W236) D269-T296 (V279) S304-A330 (L329) V343-N367 (S360)
GLR E127-L163 (L156) T172-R199 (F184) S217-L255 (L249) R261-F289 (W272) M301-R334 (A314) Y343-F367 (V364) G375-L403 (A397)
MGLU1 I591-L616 (T607) R628-I649 (I638) T654-I685 (I682) A703-M727 (I714) N750-T774 (L763) E783-G807 (A800) K811-I839 (L827)
MGLU5 P578-I603 (T594) R615-I636 (I625) Q641-K677 (A669) A690-M714 (I701) N737-T761 (L750) E770-G794 (A787) K798-A827 (L814)
SMO E224-A254 (T245) P263-F285 (F274) L312-K344 (W339) T357-V378 (W365) Y397-N432 (V411) N446-F475 (I465) L515-V536 (S533)
Table B.1: The start and end of each transmembrane helix for known crystal structrures. The
residue in parenthesis is Ballesteros-Weinstein .50 residue. Section 2.4 describes how the helix start



















































































RHO 208 143 127 132 120 136 123 115 111 108 126 117 119 106 106 115 124 138 128 129 136 124 117 107 91 80 87 79 100
RHOact 143 204 111 121 130 124 111 113 130 107 131 112 107 112 100 134 104 123 116 114 119 116 120 116 90 79 83 81 95
Beta1AR 127 111 192 177 143 139 125 143 141 136 139 128 120 106 111 115 108 137 123 122 128 123 118 104 85 82 79 72 98
Beta2AR 132 121 177 210 159 148 136 146 142 140 149 132 128 111 118 124 116 141 132 128 136 131 123 114 90 86 86 82 106
Beta2ARact 120 130 143 159 198 133 125 132 151 126 149 126 109 110 105 133 102 122 114 115 119 117 116 120 89 75 83 81 92
D3 136 124 139 148 133 196 138 130 130 118 148 125 135 119 119 129 124 141 136 132 140 134 126 114 97 87 83 81 107
H1 123 111 125 136 125 138 189 132 129 128 140 120 125 105 112 118 106 126 123 115 120 120 114 109 92 81 82 83 96
M2 115 113 143 146 132 130 132 184 150 155 133 114 116 102 110 121 102 127 117 118 116 120 112 108 81 76 78 76 98
M2act 111 130 141 142 151 130 129 150 201 147 145 121 115 112 109 139 103 128 115 110 115 115 123 121 92 79 79 82 100
M3 108 107 136 140 126 118 128 155 147 179 132 111 110 103 103 110 92 124 114 110 114 112 113 108 78 76 76 74 91
5HT1B 126 131 139 149 149 148 140 133 145 132 210 138 117 118 114 129 106 131 120 119 125 117 121 116 103 86 82 83 101
5HT2B 117 112 128 132 126 125 120 114 121 111 138 198 106 113 91 112 104 116 103 108 108 105 102 91 82 75 79 74 95
A2A 119 107 120 128 109 135 125 116 115 110 117 106 194 145 108 114 99 128 124 117 118 123 119 101 85 82 82 79 92
A2Aact 106 112 106 111 110 119 105 102 112 103 118 113 145 199 93 116 89 111 108 105 108 111 117 96 85 74 74 71 76
S1P1 106 100 111 118 105 119 112 110 109 103 114 91 108 93 172 103 97 124 119 112 120 118 104 112 100 91 85 85 98
NTS1act 115 134 115 124 133 129 118 121 139 110 129 112 114 116 103 213 117 136 123 117 120 128 132 120 95 79 86 86 97
CXCR4 124 104 108 116 102 124 106 102 103 92 106 104 99 89 97 117 215 149 131 134 146 141 127 119 90 79 84 82 105
CCR5 138 123 137 141 122 141 126 127 128 124 131 116 128 111 124 136 149 232 151 155 166 161 143 137 106 98 96 90 108
KappaOR 128 116 123 132 114 136 123 117 115 114 120 103 124 108 119 123 131 151 197 156 159 163 131 118 95 83 89 86 101
MuOR 129 114 122 128 115 132 115 118 110 110 119 108 117 105 112 117 134 155 156 188 158 162 126 115 90 87 83 82 96
NOP 136 119 128 136 119 140 120 116 115 114 125 108 118 108 120 120 146 166 159 158 201 166 142 128 97 86 94 89 103
DeltaOR 124 116 123 131 117 134 120 120 115 112 117 105 123 111 118 128 141 161 163 162 166 199 137 124 93 84 88 85 98
PAR1 117 120 118 123 116 126 114 112 123 113 121 102 119 117 104 132 127 143 131 126 142 137 232 153 103 80 87 81 100
P2Y12 107 116 104 114 120 114 109 108 121 108 116 91 101 96 112 120 119 137 118 115 128 124 153 237 103 87 92 90 105
CRF1 91 90 85 90 89 97 92 81 92 78 103 82 85 85 100 95 90 106 95 90 97 93 103 103 195 107 86 89 106
GLR 80 79 82 86 75 87 81 76 79 76 86 75 82 74 91 79 79 98 83 87 86 84 80 87 107 178 86 89 92
MGLU1 87 83 79 86 83 83 82 78 79 76 82 79 82 74 85 86 84 96 89 83 94 88 87 92 86 86 213 178 94
MGLU5 79 81 72 82 81 81 83 76 82 74 83 74 79 71 85 86 82 90 86 82 89 85 81 90 89 89 178 202 93
SMO 100 95 98 106 92 107 96 98 100 91 101 95 92 76 98 97 105 108 101 96 103 98 100 105 106 92 94 93 212
Figure B.1: Number of inter-helical contacts common to each pair of protein structures for the final
sequence alignment. A contact is defined as any two heavy atoms closer than the sum of their Van



















































































RHO 0.00 2.22 2.12 2.07 3.21 1.68 1.96 2.25 2.66 2.40 2.15 2.00 2.36 2.72 2.26 2.91 2.16 2.08 2.50 1.85 1.86 1.99 2.62 2.91 3.21 2.88 3.14 3.25 3.03
RHOact 2.22 0.00 2.49 2.35 2.05 2.53 2.28 2.66 1.84 2.31 1.99 2.09 2.69 2.40 2.74 2.41 2.80 2.52 3.02 2.68 2.84 2.50 2.47 2.90 3.45 3.01 3.09 3.23 3.15
Beta1AR 2.12 2.49 0.00 0.60 2.54 1.38 1.53 1.34 2.09 1.53 1.51 1.91 1.89 2.58 1.77 2.70 2.75 2.24 2.32 2.32 2.20 2.21 2.96 3.14 3.14 2.85 2.95 3.11 3.09
Beta2AR 2.07 2.35 0.60 0.00 2.45 1.36 1.38 1.40 2.01 1.42 1.35 1.83 1.86 2.48 1.86 2.52 2.64 2.26 2.16 2.26 2.10 2.09 2.86 3.08 3.06 2.70 2.89 3.06 3.09
Beta2ARact 3.21 2.05 2.54 2.45 0.00 3.11 2.90 2.63 1.38 1.99 1.66 2.49 3.09 2.78 3.46 2.18 3.48 3.15 3.29 3.43 3.34 2.65 3.04 2.59 3.81 3.38 3.14 3.36 3.57
D3 1.68 2.53 1.38 1.36 3.11 0.00 1.36 1.66 2.36 1.80 1.44 1.71 1.58 2.12 1.61 2.36 2.01 1.80 1.84 1.64 1.58 1.70 2.75 2.79 2.63 2.54 2.79 2.91 2.44
H1 1.96 2.28 1.53 1.38 2.90 1.36 0.00 1.48 2.19 1.35 1.44 1.75 1.94 2.35 1.87 2.43 2.12 1.79 1.83 1.79 1.71 1.69 2.65 2.76 2.81 2.67 2.89 2.98 2.56
M2 2.25 2.66 1.34 1.40 2.63 1.66 1.48 0.00 2.23 1.10 1.96 2.12 2.06 2.72 1.95 2.96 2.52 2.13 2.19 2.12 2.06 2.08 3.26 3.16 3.16 3.06 3.04 3.19 2.97
M2act 2.66 1.84 2.09 2.01 1.38 2.36 2.19 2.23 0.00 1.72 1.31 1.89 2.44 2.14 2.68 2.02 3.12 2.88 2.82 2.89 2.72 2.55 2.83 2.87 3.15 3.19 2.89 3.09 3.40
M3 2.40 2.31 1.53 1.42 1.99 1.80 1.35 1.10 1.72 0.00 1.77 1.99 2.03 2.48 1.97 2.62 2.70 2.29 2.29 2.40 2.23 2.22 3.13 3.14 3.12 3.01 2.86 3.04 3.05
5HT1B 2.15 1.99 1.51 1.35 1.66 1.44 1.44 1.96 1.31 1.77 0.00 1.64 1.92 2.01 2.15 1.99 2.59 2.37 2.33 2.35 2.21 2.24 2.68 2.97 2.83 2.76 2.75 2.90 3.03
5HT2B 2.00 2.09 1.91 1.83 2.49 1.71 1.75 2.12 1.89 1.99 1.64 0.00 2.07 2.07 2.25 2.40 2.55 2.13 2.26 2.29 2.38 2.31 2.84 3.14 3.02 2.85 2.85 2.99 2.86
A2A 2.36 2.69 1.89 1.86 3.09 1.58 1.94 2.06 2.44 2.03 1.92 2.07 0.00 1.63 1.70 2.51 2.65 2.22 2.53 2.33 2.38 2.27 3.16 3.18 3.02 3.03 2.96 3.06 3.00
A2Aact 2.72 2.40 2.58 2.48 2.78 2.12 2.35 2.72 2.14 2.48 2.01 2.07 1.63 0.00 2.34 2.08 2.98 2.79 3.07 2.83 2.85 2.75 3.06 3.10 2.81 3.07 3.00 3.15 3.11
S1P1 2.26 2.74 1.77 1.86 3.46 1.61 1.87 1.95 2.68 1.97 2.15 2.25 1.70 2.34 0.00 3.02 2.60 2.12 2.74 2.24 2.15 2.28 3.07 3.19 2.76 2.90 2.74 2.83 2.81
NTS1act 2.91 2.41 2.70 2.52 2.18 2.36 2.43 2.96 2.02 2.62 1.99 2.40 2.51 2.08 3.02 0.00 2.89 3.06 2.63 2.82 2.67 2.52 2.43 2.83 2.99 2.90 3.00 3.19 3.31
CXCR4 2.16 2.80 2.75 2.64 3.48 2.01 2.12 2.52 3.12 2.70 2.59 2.55 2.65 2.98 2.60 2.89 0.00 1.79 2.32 1.78 1.97 1.87 2.89 2.81 3.13 2.93 3.14 3.25 2.52
CCR5 2.08 2.52 2.24 2.26 3.15 1.80 1.79 2.13 2.88 2.29 2.37 2.13 2.22 2.79 2.12 3.06 1.79 0.00 2.41 1.74 1.83 1.79 2.75 3.16 3.24 3.04 3.12 3.20 2.80
KappaOR 2.50 3.02 2.32 2.16 3.29 1.84 1.83 2.19 2.82 2.29 2.33 2.26 2.53 3.07 2.74 2.63 2.32 2.41 0.00 1.41 1.59 1.45 2.80 3.46 3.25 2.88 3.16 3.38 3.25
MuOR 1.85 2.68 2.32 2.26 3.43 1.64 1.79 2.12 2.89 2.40 2.35 2.29 2.33 2.83 2.24 2.82 1.78 1.74 1.41 0.00 1.02 0.84 2.77 2.91 2.96 2.64 3.11 3.27 2.66
NOP 1.86 2.84 2.20 2.10 3.34 1.58 1.71 2.06 2.72 2.23 2.21 2.38 2.38 2.85 2.15 2.67 1.97 1.83 1.59 1.02 0.00 1.09 2.59 3.24 2.99 2.73 3.06 3.20 2.82
DeltaOR 1.99 2.50 2.21 2.09 2.65 1.70 1.69 2.08 2.55 2.22 2.24 2.31 2.27 2.75 2.28 2.52 1.87 1.79 1.45 0.84 1.09 0.00 2.52 2.67 3.09 2.75 3.12 3.32 2.70
PAR1 2.62 2.47 2.96 2.86 3.04 2.75 2.65 3.26 2.83 3.13 2.68 2.84 3.16 3.06 3.07 2.43 2.89 2.75 2.80 2.77 2.59 2.52 0.00 2.23 3.59 3.35 3.43 3.66 3.52
P2Y12 2.91 2.90 3.14 3.08 2.59 2.79 2.76 3.16 2.87 3.14 2.97 3.14 3.18 3.10 3.19 2.83 2.81 3.16 3.46 2.91 3.24 2.67 2.23 0.00 3.43 3.24 3.27 3.52 3.31
CRF1 3.21 3.45 3.14 3.06 3.81 2.63 2.81 3.16 3.15 3.12 2.83 3.02 3.02 2.81 2.76 2.99 3.13 3.24 3.25 2.96 2.99 3.09 3.59 3.43 0.00 2.42 3.17 3.17 2.87
GLR 2.88 3.01 2.85 2.70 3.38 2.54 2.67 3.06 3.19 3.01 2.76 2.85 3.03 3.07 2.90 2.90 2.93 3.04 2.88 2.64 2.73 2.75 3.35 3.24 2.42 0.00 2.85 2.94 2.52
MGLU1 3.14 3.09 2.95 2.89 3.14 2.79 2.89 3.04 2.89 2.86 2.75 2.85 2.96 3.00 2.74 3.00 3.14 3.12 3.16 3.11 3.06 3.12 3.43 3.27 3.17 2.85 0.00 0.73 3.10
MGLU5 3.25 3.23 3.11 3.06 3.36 2.91 2.98 3.19 3.09 3.04 2.90 2.99 3.06 3.15 2.83 3.19 3.25 3.20 3.38 3.27 3.20 3.32 3.66 3.52 3.17 2.94 0.73 0.00 3.13
SMO 3.03 3.15 3.09 3.09 3.57 2.44 2.56 2.97 3.40 3.05 3.03 2.86 3.00 3.11 2.81 3.31 2.52 2.80 3.25 2.66 2.82 2.70 3.52 3.31 2.87 2.52 3.10 3.13 0.00


















































































RHO 100.0 100.0 20.7 21.5 21.5 27.4 20.3 21.9 22.4 20.2 21.5 21.5 24.0 23.6 21.5 22.7 22.2 23.4 19.2 23.4 21.2 22.2 18.7 18.8 12.3 11.9 10.2 10.1 14.4
RHOact 100.0 100.0 21.4 21.6 21.4 27.9 20.3 21.9 22.3 20.2 21.3 21.1 24.0 23.5 21.4 22.7 22.1 23.4 19.2 23.4 21.3 22.2 18.7 18.4 12.2 11.7 10.3 10.2 14.0
Beta1AR 20.7 21.4 100.0 68.6 69.0 42.3 37.8 30.3 30.2 34.5 45.7 40.5 37.4 36.7 29.3 22.4 24.2 26.1 28.4 26.1 27.1 28.4 21.1 23.6 14.1 12.0 9.7 11.2 8.9
Beta2AR 21.5 21.6 68.6 100.0 99.5 39.1 36.6 30.3 29.9 36.4 41.8 38.6 35.7 35.5 28.0 19.7 24.1 23.5 27.0 26.4 26.4 27.8 22.4 21.8 11.4 9.2 9.1 10.1 8.8
Beta2ARact 21.5 21.4 69.0 99.5 100.0 39.6 36.6 30.5 30.0 35.6 42.5 38.4 35.7 35.5 28.0 19.8 23.6 23.1 26.6 26.2 25.9 27.9 22.4 21.6 11.3 9.7 9.1 10.2 8.7
D3 27.4 27.9 42.3 39.1 39.6 100.0 36.4 32.3 33.5 32.3 43.6 37.6 32.7 32.5 26.8 27.8 27.8 23.9 25.8 28.9 29.3 29.5 23.7 24.5 12.6 13.8 8.5 7.3 8.7
H1 20.3 20.3 37.8 36.6 36.6 36.4 100.0 37.8 37.9 39.4 39.6 33.8 34.4 34.4 25.5 22.1 25.8 23.3 30.6 29.6 26.5 29.2 23.0 19.6 12.8 13.4 9.1 9.0 12.6
M2 21.9 21.9 30.3 30.3 30.5 32.3 37.8 100.0 100.0 73.4 35.5 31.0 26.7 26.9 28.7 24.7 23.6 22.3 29.3 28.8 27.3 28.3 24.2 22.7 11.9 8.3 11.2 8.3 10.2
M2act 22.4 22.3 30.2 29.9 30.0 33.5 37.9 100.0 100.0 72.1 35.2 31.0 26.9 26.9 28.1 24.2 23.1 22.0 28.7 28.2 26.7 28.1 23.8 22.6 11.8 8.1 11.3 8.4 10.5
M3 20.2 20.2 34.5 36.4 35.6 32.3 39.4 73.4 72.1 100.0 38.1 33.0 30.7 30.7 28.3 24.7 24.6 23.3 27.3 27.7 24.7 27.7 22.7 23.4 13.4 9.5 9.8 9.7 13.1
5HT1B 21.5 21.3 45.7 41.8 42.5 43.6 39.6 35.5 35.2 38.1 100.0 36.5 33.2 32.7 31.6 25.5 25.4 21.0 28.9 27.4 25.6 27.8 19.2 22.1 13.2 13.0 8.5 11.8 11.6
5HT2B 21.5 21.1 40.5 38.6 38.4 37.6 33.8 31.0 31.0 33.0 36.5 100.0 32.5 32.2 25.7 23.2 23.3 21.5 28.4 28.5 27.9 28.2 22.3 21.8 13.3 12.8 11.4 11.2 9.4
A2A 24.0 24.0 37.4 35.7 35.7 32.7 34.4 26.7 26.9 30.7 33.2 32.5 100.0 100.0 30.0 22.8 21.8 21.8 27.1 26.8 23.4 27.8 20.4 18.8 14.6 13.3 11.9 10.7 10.3
A2Aact 23.6 23.5 36.7 35.5 35.5 32.5 34.4 26.9 26.9 30.7 32.7 32.2 100.0 100.0 29.7 22.4 21.4 21.5 26.9 26.4 23.0 27.4 20.1 18.5 14.4 13.1 11.9 10.7 10.1
S1P1 21.5 21.4 29.3 28.0 28.0 26.8 25.5 28.7 28.1 28.3 31.6 25.7 30.0 29.7 100.0 23.6 22.8 22.2 21.4 21.4 21.6 22.2 17.0 20.0 11.0 12.8 12.6 9.1 10.8
NTS1act 22.7 22.7 22.4 19.7 19.8 27.8 22.1 24.7 24.2 24.7 25.5 23.2 22.8 22.4 23.6 100.0 25.5 22.0 29.1 23.0 28.0 24.8 20.7 20.0 12.1 11.7 7.5 5.1 10.1
CXCR4 22.2 22.1 24.2 24.1 23.6 27.8 25.8 23.6 23.1 24.6 25.4 23.3 21.8 21.4 22.8 25.5 100.0 33.8 28.4 30.1 32.0 27.7 25.7 27.2 14.8 11.9 10.3 10.2 10.1
CCR5 23.4 23.4 26.1 23.5 23.1 23.9 23.3 22.3 22.0 23.3 21.0 21.5 21.8 21.5 22.2 22.0 33.8 100.0 28.2 26.6 27.8 26.6 23.2 30.3 14.7 12.1 10.7 8.9 7.9
KappaOR 19.2 19.2 28.4 27.0 26.6 25.8 30.6 29.3 28.7 27.3 28.9 28.4 27.1 26.9 21.4 29.1 28.4 28.2 100.0 71.0 61.2 71.1 26.3 28.5 16.1 13.6 5.6 7.3 7.2
MuOR 23.4 23.4 26.1 26.4 26.2 28.9 29.6 28.8 28.2 27.7 27.4 28.5 26.8 26.4 21.4 23.0 30.1 26.6 71.0 100.0 61.9 72.0 26.4 28.7 15.7 14.4 6.8 8.9 5.8
NOP 21.2 21.3 27.1 26.4 25.9 29.3 26.5 27.3 26.7 24.7 25.6 27.9 23.4 23.0 21.6 28.0 32.0 27.8 61.2 61.9 100.0 61.4 29.2 27.2 17.6 15.6 6.8 8.9 8.5
DeltaOR 22.2 22.2 28.4 27.8 27.9 29.5 29.2 28.3 28.1 27.7 27.8 28.2 27.8 27.4 22.2 24.8 27.7 26.6 71.1 72.0 61.4 100.0 27.9 26.0 14.4 16.8 8.4 9.4 9.6
PAR1 18.7 18.7 21.1 22.4 22.4 23.7 23.0 24.2 23.8 22.7 19.2 22.3 20.4 20.1 17.0 20.7 25.7 23.2 26.3 26.4 29.2 27.9 100.0 25.2 15.6 14.8 7.3 9.5 10.6
P2Y12 18.8 18.4 23.6 21.8 21.6 24.5 19.6 22.7 22.6 23.4 22.1 21.8 18.8 18.5 20.0 20.0 27.2 30.3 28.5 28.7 27.2 26.0 25.2 100.0 14.4 17.0 10.9 11.9 8.4
CRF1 12.3 12.2 14.1 11.4 11.3 12.6 12.8 11.9 11.8 13.4 13.2 13.3 14.6 14.4 11.0 12.1 14.8 14.7 16.1 15.7 17.6 14.4 15.6 14.4 100.0 37.2 13.0 16.4 17.0
GLR 11.9 11.7 12.0 9.2 9.7 13.8 13.4 8.3 8.1 9.5 13.0 12.8 13.3 13.1 12.8 11.7 11.9 12.1 13.6 14.4 15.6 16.8 14.8 17.0 37.2 100.0 11.0 13.1 15.1
MGLU1 10.2 10.3 9.7 9.1 9.1 8.5 9.1 11.2 11.3 9.8 8.5 11.4 11.9 11.9 12.6 7.5 10.3 10.7 5.6 6.8 6.8 8.4 7.3 10.9 13.0 11.0 100.0 74.5 15.8
MGLU5 10.1 10.2 11.2 10.1 10.2 7.3 9.0 8.3 8.4 9.7 11.8 11.2 10.7 10.7 9.1 5.1 10.2 8.9 7.3 8.9 8.9 9.4 9.5 11.9 16.4 13.1 74.5 100.0 11.6
SMO 14.4 14.0 8.9 8.8 8.7 8.7 12.6 10.2 10.5 13.1 11.6 9.4 10.3 10.1 10.8 10.1 10.1 7.9 7.2 5.8 8.5 9.6 10.6 8.4 17.0 15.1 15.8 11.6 100.0



















































































RHO 100.0 100.0 42.9 44.5 44.5 46.7 44.2 42.9 43.8 42.0 46.0 45.0 46.0 45.3 40.0 44.9 40.4 45.8 46.8 47.8 40.9 44.9 38.4 35.0 31.6 32.1 27.3 25.8 25.1
RHOact 100.0 100.0 43.3 44.1 43.7 47.2 44.2 42.9 43.6 42.0 46.0 45.1 46.0 45.1 40.3 44.4 40.2 45.3 45.7 47.3 40.6 44.4 38.9 34.3 30.9 31.0 27.4 26.0 24.9
Beta1AR 42.9 43.3 100.0 82.8 82.8 61.7 62.2 55.6 55.0 56.7 61.8 58.0 54.4 53.8 48.7 48.5 50.5 48.2 52.7 49.7 52.3 52.8 45.7 45.1 31.0 34.4 26.1 24.7 29.3
Beta2AR 44.5 44.1 82.8 100.0 99.5 62.4 62.4 56.1 55.9 57.9 63.7 58.9 51.0 50.5 49.2 46.0 49.2 47.5 50.5 49.3 48.8 50.5 44.3 43.1 28.6 31.8 22.7 24.2 24.9
Beta2ARact 44.5 43.7 82.8 99.5 100.0 62.9 62.4 56.3 55.7 57.2 64.5 58.6 51.0 50.5 49.2 45.7 48.7 47.2 49.3 49.0 48.3 50.8 43.8 43.2 29.0 32.7 22.9 24.3 24.5
D3 46.7 47.2 61.7 62.4 62.9 100.0 59.0 52.8 53.8 55.6 63.6 61.9 51.5 51.3 47.9 49.5 47.4 44.7 50.0 50.8 48.0 50.3 42.9 41.1 29.5 29.6 26.1 25.3 23.9
H1 44.2 44.2 62.2 62.4 62.4 59.0 100.0 57.0 57.4 57.4 59.9 59.0 49.2 49.7 45.2 46.8 46.4 45.6 53.6 52.6 52.0 53.1 49.0 42.3 30.6 36.0 27.3 27.0 30.2
M2 42.9 42.9 55.6 56.1 56.3 52.8 57.0 100.0 100.0 85.4 56.3 53.8 50.8 50.8 47.9 48.5 44.1 45.7 51.0 49.0 48.0 51.0 43.4 39.7 28.1 29.5 29.2 29.4 26.7
M2act 43.8 43.6 55.0 55.9 55.7 53.8 57.4 100.0 100.0 85.6 55.8 54.0 51.3 50.7 46.9 48.5 44.7 45.0 50.5 48.5 47.5 50.8 44.1 39.5 28.9 29.4 29.4 29.6 26.8
M3 42.0 42.0 56.7 57.9 57.2 55.6 57.4 85.4 85.6 100.0 53.6 53.9 50.8 50.5 45.7 48.9 44.5 45.6 50.0 47.2 45.9 48.7 46.4 39.6 30.2 27.5 29.9 30.1 27.9
5HT1B 46.0 46.0 61.8 63.7 64.5 63.6 59.9 56.3 55.8 53.6 100.0 59.9 50.3 49.5 49.7 49.0 46.1 40.0 53.2 50.3 47.2 51.0 40.4 39.2 29.1 33.7 23.3 25.3 25.3
5HT2B 45.0 45.1 58.0 58.9 58.6 61.9 59.0 53.8 54.0 53.9 59.9 100.0 49.5 49.5 48.2 45.3 44.8 44.4 49.5 48.8 48.6 49.5 40.8 40.6 30.9 31.1 26.7 28.1 24.1
A2A 46.0 46.0 54.4 51.0 51.0 51.5 49.2 50.8 51.3 50.8 50.3 49.5 100.0 100.0 47.4 46.6 44.7 44.7 49.7 47.5 45.8 48.5 40.3 40.6 31.9 35.1 26.6 24.2 26.5
A2Aact 45.3 45.1 53.8 50.5 50.5 51.3 49.7 50.8 50.7 50.5 49.5 49.5 100.0 100.0 46.9 45.9 44.3 45.0 49.3 47.3 45.1 48.2 40.2 40.0 32.1 34.6 26.7 24.2 26.6
S1P1 40.0 40.3 48.7 49.2 49.2 47.9 45.2 47.9 46.9 45.7 49.7 48.2 47.4 46.9 100.0 41.9 42.3 43.3 46.4 44.8 43.3 44.4 39.2 39.5 29.1 29.3 28.2 27.4 25.4
NTS1act 44.9 44.4 48.5 46.0 45.7 49.5 46.8 48.5 48.5 48.9 49.0 45.3 46.6 45.9 41.9 100.0 47.5 40.7 49.3 48.5 49.3 49.0 43.3 41.5 24.2 26.4 21.8 18.8 21.7
CXCR4 40.4 40.2 50.5 49.2 48.7 47.4 46.4 44.1 44.7 44.5 46.1 44.8 44.7 44.3 42.3 47.5 100.0 62.3 55.9 53.4 53.9 54.5 48.5 50.0 31.7 32.6 21.7 22.6 25.0
CCR5 45.8 45.3 48.2 47.5 47.2 44.7 45.6 45.7 45.0 45.6 40.0 44.4 44.7 45.0 43.3 40.7 62.3 100.0 57.8 55.6 52.2 55.1 52.2 51.2 33.7 34.2 24.9 22.9 28.4
KappaOR 46.8 45.7 52.7 50.5 49.3 50.0 53.6 51.0 50.5 50.0 53.2 49.5 49.7 49.3 46.4 49.3 55.9 57.8 100.0 86.5 76.6 84.8 52.2 49.3 35.5 33.2 24.7 23.6 29.2
MuOR 47.8 47.3 49.7 49.3 49.0 50.8 52.6 49.0 48.5 47.2 50.3 48.8 47.5 47.3 44.8 48.5 53.4 55.6 86.5 100.0 74.8 83.1 49.0 47.5 33.5 32.8 22.0 22.9 25.9
NOP 40.9 40.6 52.3 48.8 48.3 48.0 52.0 48.0 47.5 45.9 47.2 48.6 45.8 45.1 43.3 49.3 53.9 52.2 76.6 74.8 100.0 73.9 50.7 46.1 31.9 32.2 23.7 22.9 25.4
DeltaOR 44.9 44.4 52.8 50.5 50.8 50.3 53.1 51.0 50.8 48.7 51.0 49.5 48.5 48.2 44.4 49.0 54.5 55.1 84.8 83.1 73.9 100.0 51.5 44.6 32.8 33.0 24.2 24.4 28.7
PAR1 38.4 38.9 45.7 44.3 43.8 42.9 49.0 43.4 44.1 46.4 40.4 40.8 40.3 40.2 39.2 43.3 48.5 52.2 52.2 49.0 50.7 51.5 100.0 48.5 32.8 32.7 23.7 22.3 27.5
P2Y12 35.0 34.3 45.1 43.1 43.2 41.1 42.3 39.7 39.5 39.6 39.2 40.6 40.6 40.0 39.5 41.5 50.0 51.2 49.3 47.5 46.1 44.6 48.5 100.0 35.0 33.0 29.1 27.1 27.2
CRF1 31.6 30.9 31.0 28.6 29.0 29.5 30.6 28.1 28.9 30.2 29.1 30.9 31.9 32.1 29.1 24.2 31.7 33.7 35.5 33.5 31.9 32.8 32.8 35.0 100.0 58.0 28.4 29.8 33.0
GLR 32.1 31.0 34.4 31.8 32.7 29.6 36.0 29.5 29.4 27.5 33.7 31.1 35.1 34.6 29.3 26.4 32.6 34.2 33.2 32.8 32.2 33.0 32.7 33.0 58.0 100.0 25.6 26.9 30.6
MGLU1 27.3 27.4 26.1 22.7 22.9 26.1 27.3 29.2 29.4 29.9 23.3 26.7 26.6 26.7 28.2 21.8 21.7 24.9 24.7 22.0 23.7 24.2 23.7 29.1 28.4 25.6 100.0 85.9 31.0
MGLU5 25.8 26.0 24.7 24.2 24.3 25.3 27.0 29.4 29.6 30.1 25.3 28.1 24.2 24.2 27.4 18.8 22.6 22.9 23.6 22.9 22.9 24.4 22.3 27.1 29.8 26.9 85.9 100.0 28.9
SMO 25.1 24.9 29.3 24.9 24.5 23.9 30.2 26.7 26.8 27.9 25.3 24.1 26.5 26.6 25.4 21.7 25.0 28.4 29.2 25.9 25.4 28.7 27.5 27.2 33.0 30.6 31.0 28.9 100.0




Alignment of GPCR Crystal
Structures
In Figures figs. C.1 to C.7 we show the sequence alignment for the TM regions of the crystal
structures. The central blue column labels the n.50 residues in BW numbering and the green color
denotes extent of the TM regions for each crystal structure individually. Active structures (labels
with extension act) are listed separately, as the TM length differ slightly. Prolines are highlighted in
red, since they often cause helix kinks, and so are structurally important. The consensus sequence
in the lower part of each figure mostly agrees with class A residues, because most of the crystal



























































































A P Q Y Y L A E P W Q F S M L A A Y M F L L I M L G F P I N F L T L Y V T V Q H K
A P Q Y Y L A E P W Q F S M L A A Y M F L L I M L G F P I N F L T L Y V T V Q H K
Q V S A E L L SQ Q W E A G M S L L M A L V V L L I V A G N V L V I A A I G S T Q
H D V T Q E R D E V W V V G M G I V M S L I V L A I V F G N V L V I T A I A K F E
H D V T Q E R D E V W V V G M G I V M S L I V L A I V F G N V L V I T A I A K F E
E N S T G A SQ A R P H A Y Y A L S Y C A L I L A I V F G N G L V C M A V L K E R
E G N K T T M A S P Q L M P L V V V L S T I C L V T V G L N L L V L Y A V R S E R
L A L T S P Y K T F E V V F I V L V A G S L S L V T I I G N I L V M V S I K V N R
L A L T S P Y K T F E V V F I V L V A G S L S L V T I I G N I L V M V S I K V N R
S D P L G G H T IW Q V V F I A F L T G F L A L V T I I G N I L V I V A F K V N K
Y I Y Q D S I S L P W K V L L V M L L A L I T L A T T L S N A F V I A T V Y R T R
M K Q I V E EQ G N K L H W A A L L I L M V I I P T I G G N T L V I L A V S L E K
- - - - - - M P I M G S S V Y I T V E L A I A V L A I L G N V L V C W A V W L N S
- - - - - - M P I M G S S V Y I T V E L A I A V L A I L G N V L V C W A V W L N S
K L N I S A D K E N S I K L T S V V F I L I C C F I I L E N I F V L L T IW K T K
S D L D V N T D I Y S K V L V T A I Y L A L F V V G T V G N S V T L F T L A R K K
P C F R E E N A N F N K I F L P T I Y S I I F L T G I V G N G L V I L V M G Y Q K
P C Q K I N V K Q I A A R L L P P L Y S L V F I F G F V G N M L V I L I L I N Y K
Q L E P A H I S P A I P V I I T A V Y S V V F V V G L V G N S L V M F V I I R Y T
C P Q T G S P S M V T A I T I M A L Y S I V C V V G L F G N F L V M Y V I V R Y T
A S H G A F L P L G L K V T I V G L Y L A V C V G G L L G N C L V M Y V I L R H T
P G A R S A S S L A L A I A I T A L Y S A V C A V G L L G N V L V M F G I V R Y T
D A S G Y L T S SW L T L F V P S V Y T G V F V V S L P L N I M A I V V F I L K M
T S L C T R D Y K I T Q V L F P L L Y T V L F F V G L I T N G L A M R I F FQ I R
I L N E E K K S K V H Y H V A A I I N Y L G H C I S L V A L L V A F V L F L R A R
E I E V Q K E V A K M Y S S FQ V M Y T V G Y S L S L G A L L L A L A I L G G L S
C E P I P V R Y L EW S N I E S I I A I A F S C L G I L V T L F V T L I F V L Y R
C D L S P V Q Y L R W G D P A P I A A V V F A C L G L L A T L F V T V V F I I Y R
Q C Q N P L F T E A E H Q D M H S Y I A A F G A V T G L C T L F T L A T F V A D W
30 35 40 45 50 55 60
+ D Q T S L+ S L+ W V V + I A + V Y S L+ F L V G + L G N + L V I V A I V R Y R



























































































R T P L N Y I L L N L A V A D L F M V F G G F T T T L Y T S L H
R T P L N Y I L L N L A V A D L F M V F G G F T T T L Y T S L H
Q T L T N L F I T S L A C A D L V V G L L V V P F G A T L V V R
Q T V T N Y F I T S L A C A D L V M G L A V V P F G A A H I L M
Q T V T N Y F I T S L A C A D L V M G L A V V P F G A A H I L T
Q T T T N Y L V V S L A V A D L L V A T L V M P W V V Y L E V T
H T V G N L Y I V S L S V A D L I V G A V V M P M N I L Y L L M
Q T V N N Y F L F S L A C A D L I I G V F S M N L Y T L Y T V I
Q T V N N Y F L F S L A C A D L I I G V F S M N L Y T L Y T V I
K T V N N Y F L L S L A C A D L I I G V I S M N L F T T Y I I M
H T P A N Y L I A S L A V T D L L V S I L V M P I S T M Y T V T
Q Y A T N Y F L M S L A V A D L L V G L F V M P I A L L T I M F
Q N V T N Y F V V S L A A A D I A V G V L A I P F A I T I S T G
Q N V T N Y F V V S L A A A D I A V G V L A I P F A I T I S T G
H R P M Y Y F I G N L A L S D L L A G V A Y T A N L L L S G A T
Q S T V H Y H L G S L A L S D L L I L L L A M P V E L Y N F IW
R S M T D K Y R L H L S V A D L L F V I T L P FW A V D A V A N
K S M T D I Y L L N L A I S D L F F L L T V P FW A H Y A A A Q
K T A T N I Y I F N L A L A D A L V T T T M P FQ S T V Y L M N
K T A T N I Y I F N L A L A D A L A T S T L P FQ S V N Y L M G
K T A T N I Y I F N L A L A D T L V L L T L P FQ G T D I L L G
K T A T N I Y I F N L A L A D A L A T S T L P FQ S A K Y L M E
K K P A V V Y M L H L A T A D V L F V S V L P F K I S Y Y F S G
K S N F I I F L K N T V I S D L L M I L T F P F K I L S D A K L
R C L R N I I H A N L I A A F I L R N A T W F V V Q L T M S P E
H C T R N A I H A N L F A S F V L K A S S V L V I D G L L R T R
K S S S R E L C Y I I L A G I F L G Y V C P F T L I A K P - - -
K S S S R E L C Y I I L A G I C L G Y L C T F C L I A K P - - -
N R Y P A V I L F Y V N A C F F V G S I G W L A Q F M D G A R R
40 45 50 55 60 65
+ T V T N Y F+ F S L A + A D L L V G L T V + P + A L+ Y + L G



























































































F V F G P T G C N L E G F F A T L G G E I A LW S L V V L A I E R Y V V V C K P M
F V F G P T G C N L E G F F A T L G G E I A LW S L V V L A I E R Y V V V C K P M
W LW G S F L C E LW T S L D V L C V T A S I E T L C V I A I D R Y L A I T S P F
W T F G N FW C E FW T S I D V L C V T A S I E T L C V I A V D R Y F A I T S P F
W T F G N FW C E FW T S I D V L C V T A S I E T L C V I A V D R Y F A I T S P F
W N F S R I C C D V F V T L D V M M C T A S IW N L C A I S I D R Y T A V V M P V
W S L G R P L C L FW L S M D Y V A S T A S I F S V F I L C I D R Y R S V Q Q P L
W P L G P V V C D LW L A L D Y V V S N A S V M N L L I I S F D R Y F C V T K P L
W P L G P V V C D LW L A L D Y V V S N A S V M N L L I I S F D R Y F C V T K P L
W A L G N L A C D LW L S I D Y V A S N A S V M N L L V I S F D R Y F S I T R P L
W T L G Q V V C D FW L S S D I T C C T A S IW H L C V I A L D R Y W A I T D A V
W P L P L V L C P A W L F L D V L F S T A S IW H L C A I S V D R Y I A I K K P I
F C A A C H G C L F I A C F V L V L T Q S S I F S L L A I A I D R Y I A I R I P L
F C A A C H G C L F I A C F V L V L T Q S S I F S L L A I A I D R Y I A I R I P L
Y K L T P A Q W F L R E G S M F V A L S A S V F S L L A I A I E R Y I T M L K M K
W A F G D A G C R G Y Y F L R D A C T Y A T A L N V A S L S V A R Y L A I C H P F
W Y F G N F L C K A V H V I Y T V N L Y S S V W I L A F I S L D R Y L A I V H A T
W D F G N T M C Q L L T G L Y F I G F F S G I F F I I L L T I D R Y L A V V H A V
W P F G D V L C K I V L S I D Y Y N M F T S I F T L T M M S V D R Y I A V C H P V
W P F G N I L C K I V I S I D Y Y N M F T S I F T L C T M S V D R Y I A V C H P V
W P F G N A L C K T V I A I D Y Y N M F T S T F T L T A M S V D R Y V A I C H P I
W P F G E L L C K A V L S I D Y Y N M F T S I F T L T M M S V D R Y I A V C H P V
W Q F G S E L C R F V T A A F Y C N M Y A S I L L M T V I S I D R F L A V V Y P M
G P L R T F V C Q V T S V I F Y F T M Y I S I S F L G L I T I D R Y Q K T T R P F
H Q S N V G W C R L V T A A Y N Y F H V T N F FW M F G E G C Y L H T A I V L T -
S D G A V A G C R V A A V F M Q Y G I V A N Y C W L L V E G L Y L H N L L G L A -
- - - T T T S C Y LQ R L L V G L S S A M C Y S A L V T K T N R I A R I L A G S K
- - - K Q I Y C Y LQ R I G I G L S P A M S Y S A L V T K T Y R A A R I L A M S K
T S N E T L S C V I I F V I V Y Y A L M A G V V W F V V L T Y A W H T S F K A L G
25 30 35 40 45 50 55
W P F G N + L C + LW L S I D Y + N + T A S I F T L+ V I S I D R Y I A I T H P +



























































































N F R F G E N H A I M G V A F T W V M A L A C A A P P L V G W S R Y I
N F R F G E N H A I M G V A F T W V M A L A C A A P P L V G W S R Y I
Q S L M T R A R A K V I I C T V W A I S A L V S F L P I M M H W W R D
Q S L L T K N K A R V I I L M V W I V S G L T S F L P IQ M H W Y R A
Q S L L T K N K A R V I I L M V W I V S G L T S F L P IQ M H W Y R A
T G Q S S C R R V A L M I T A V W V L A F A V S C P L L F G F N T T G
L K Y R T K T R A S A T I L G A W F L S F LW V I P I L G W N H F M Q
P V K R T T K M A G M M I A A A W V L S F I LW A P A I L FW Q F I V
P V K R T T K M A G M M I A A A W V L S F I LW A P A I L FW Q F I V
R A K R T T K R A G V M I G L A W V I S F V LW A P A I L FW Q Y F V
S A K R T P K R A A V M I A L V W V F S I S I S L P P F FW R Q A K A
N Q Y N S R A T A F I K I T V V W L I S I G I A I P V P I K G I E T D
N G L V T G T R A K G I I A I C W V L S F A I G L T P M L G W N N C G
N G L V T G T R A K G I I A I C W V L S F A I G L T P M L G W N N C G
H N G S N N F R L F L L I S A C W V I S L I L G G L P I M G W N C I S
K T L M S R S R T K K F I S A IW L A S A L L A I P M L F T M G LQ N
Q R P R K L L A E K V V Y V G V W I P A L L L T I P D F I F A N V S E
L K A R T V T F G V V T S V I T W V V A V F A S L P N I I F T R SQ K
L D F R T P L K A K I I N I C IW L L S S S V G I S A I V L G G T K V
L D F R T P R N A K I V N V C N W I L S S A I G L P V M F M A T T K Y
L D V R T S S K A Q A V N V A IW A L A S V V G V P V A I M G S A Q V
L D F R T P A K A K L I N I C IW V L A S G V G V P I M V M A V T Q P
L SW R T L G R A S F T C L A IW A L A I A G V V P L L L K EQ T IQ
S N P K N L L G A K I L S V V IW A F M F L L S L P N M I L T N R Q P
- Y S T D R L R A W M F I C I G W G V P F P I I V A W A I G K L Y Y D
- T L P E R S F F S L Y L G I G W G A P M L F V V P W A V V K C L F E
P R F M S A W A Q V I I A S I L I S V Q L T L V V T L I I M E P P M P
P R F M S A C A Q L V I A F I L I C IQ L G I I V A L F I M E P P D I
T Y Q P L S G K T S Y F H L L T W S L P F V L T V A I L A V A Q V D G
35 40 45 50 55 60 65
L+ L R T R + R A K V I I A + V W V L S F L L+ V P P I I M W + T Q V



























































































H E E T N N E S F V I Y M F V V H F I I P L I V I F F C Y G Q L V F T V K E A A A Q Q Q E S
H E E T N N E S F V I Y M F V V H F I I P L I V I F F C Y G Q L V F T V K E A A A Q Q Q E S
C D F V T N R A Y A I A S S I I S F Y I P L L I M I F V A L R V Y R E A K EQ I R K I D R C
C D F F T N Q A Y A I A S S I V S F Y V P L V I M V F V Y S R V FQ E A K R Q LQ K I D K S
C D F F T N Q A Y A I A S S I V S F Y V P L V I M V F V Y S R V FQ E A K R Q LQ K I D K S
V C S I S N P D F V I Y S S V V S F Y L P F G V T V L V Y A R I Y V V L K Q R R R K R I L T
T D F Y D V T W F K V M T A I I N F Y L P T L L M LW F Y A K I Y K A V R Q H C Q H R E L I
IQ F F S N A A V T F G T A I A A F Y L P V I I M T V L Y W H I S R A S K S R I K K D K K E
IQ F F S N A A V T F G T A I A A F Y L P V I I M T V L Y W H I S R A S K S R I K K D K K E
IQ F L S E P T I T F G T A I A A F Y M P V T I M T I L Y W R I Y K E T E K R T K E L A G L
V V N T D H I L Y T V Y S T V G A F Y F P T L L L I A L Y G R I Y V E A R S R I L K Q T P N
L T K E R F G D F M L F G S L A A F F T P L A I M I V T Y F L T I H A LQ K K A Y L V K N K
E D V V P M N Y M V Y F N F F A C V L V P L L L M L G V Y L R I F L A A R R Q L K Q M E SQ
E D V V P M N Y M V Y F N F F A C V L V P L L L M L G V Y L R I F L A A R R Q L K Q M E SQ
T V L P L Y H K H Y I L F C T T V F T L L L L S I V I L Y C R I Y S L V R T R S R R L T F R
V D T A T V K V V IQ V N T F M S F L F P M L V I S I L N T V I A N K L T V M V H Q A A EQ
P N D LW V V V FQ FQ H I M V G L I L P G I V I L S C Y C I I I S K L S H S K - - - - - -
Q Y Q FW K N FQ T L K I V I L G L V L P L L V M V I C Y S G I L K T L L R C R N E - - - -
D Y SW W D L F M K I C V F I F A F V I P V L I I I V C Y T L M I L R L K S V R L L S G S R
P T W Y W E N L L K I C V F I F A F I M P V L I I T V C Y G L M I L R L K S V R M L S G S K
P Q D Y W G P V F A I C I F L F S F I V P V L V I S V C Y S L M I R R L R G V R L L S G S -
P SW Y W D T V T K I C V F L F A F V V P I L I I T V C Y G L M L L R L R S V R L L S G S K
L L E G Y Y A Y Y F S A F S A V F F F V P L I I S T V C Y V S I I R C L S S S A V A N - - -
E F G L V W H E I V N Y I C Q V I FW I N F L I V I V C Y T L I T K E L Y R S Y V R T R G -
W A G K R P G V Y T D Y I Y Q G P M A L V L L I N F I F L F N I V R I L M T K L R A S T T -
C W T S N D N M G FW W I L R F P V F L A I L I N F F I F V R I V Q L L V A K L R A R Q M -
Y L I C N T S N L G V V A P L G Y N G L L I M S C T Y Y A F K T R N V P A N F - - - - - - -
Y L I C N T T N L G V V A P L G Y N G L L I L A C T F Y A F K T R N V P A N F - - - - - - -
F V G Y K N Y R Y R A G F V L A P I G L V L I V G G Y F L I R G V M T L F S I K S N H P G L
35 40 45 50 55 60 65 70
+ D F+ W N N + + + I Y + F I V A F Y L P L L I M T V C Y G R I+ R + L K S R + + K S G S S



























































































A T T Q K A E K E V T R M V I I M V I A F L I C W L P Y A G V A F Y I F T H -
A T T Q K A E K E V T R M V I I M V I A F L I C W L P Y A G V A F Y I F T H -
R V M A M R E H K A L K T L G I I M G V F T L C W L P F F L V N I V N V F N -
S K F C L K E H K A L K T L G I I M G T F T L C W L P F F I V N I V H V IQ -
S K F C L K E H K A L K T L G I I M G T F T L C W L P F F I V N I V H V IQ -
R G V P L R E K K A T Q M V A I V L G A F I V C W L P F F L T H V L N T H C -
G L H M N R E R K A A K Q L G F I M A A F I L C W I P Y F I F F M V I A F C -
K P P P S R E K K V T R T I L A I L L A F I I T W A P Y N V M V L I N T F C -
K P P P S R E K K V T R T I L A I L L A F I I T W A P Y N V M V L I N T F C -
R M S L I K E K K A A Q T L S A I L L A F I I T W T P Y N I M V L V N T F C -
K L M A A R E R K A T K T L G I I L G A F I V C W L P F F I I S L V M P I C K
V Q T I S N EQ R A S K V L G I V F F L F L L M W C P F F I T N I T L V L C D
R S T LQ K E V H A A K S L A I I V G L F A L C W L P L H I I N C F T F F C P
R S T LQ K E V H A A K S L A I I V G L F A L C W L P L H I I N C F T F F C P
A S R S S E N V A L L K T V I I V L S V F I A C W A P L F I L L L L D V G C K
P G R V Q A L R H G V L V A R A V V I A F V V C W L P Y H V R R L M F C Y I S
- - - G H Q K R K A L K T T V I L I L A F F A C W L P Y Y I G I S I D S F I L
- - - - K K R H R D V R L I F T I M I V Y F L FW A P Y N I V L L L N T FQ E
- E K D R N L R R I T R L V L V V V A V F V V C W T P I H I F I L V E A L G S
- E K D R N L R R I T R M V L V V V A V F I V C W T P I H I Y V I I K A L I T
R E K D R N L R R I T R L V L V V V A V F V G C W T P V Q V F V L A Q G L G V
- E K D R S L R R I T R M V L V V V G A F V V C W A P I H I F V I V W T L V D
- - - R S K K S R A L F L S A A V F C I F I I C F G P T N V L L I A H Y S F L
- V G K V P R K K V N V K V F I I I A V F F I C F V P F H F A R I P Y T L SQ
- S E T IQ A R K A V K A T L V L L P L L G I T Y M L A F V N P G E D E - - -
- H H T D Y K F R L A K S T L T L I P L L G V H E V V F A F V T D E H A Q - -
- - - - - - - - N E A K Y I A F T M Y T T C I IW L A F V P I Y F G - - - - -
- - - - - - - - N E A K Y I A F T M Y T T C I IW L A F V P I Y F G - - - - -
E K A A S K I N E T M L R L G I F G F L A F G F V L I T F S C H F Y D F F N Q
30 35 40 45 50 55 60
R + T D S K E R K A T K T L L I I V G A F I I C W L P F F I V + L V N T F C +



























































































- Q G S D F G P I F M T I P A F F A K T S A V Y N P V I Y I M M N K Q F R N C
- Q G S D F G P I F M T I P A F F A K T S A V Y N P V I Y I M M N K Q F R N C
- - R D L V P D W L F V A F N W L G Y A N S A M N P I I Y C R S P D F R K A F
- - D N L I R K E V Y I L L N W I G Y V N S G F N P L I Y C R S P D F R I A F
- - D N L I R K E V Y I L L N W I G Y V N S G F N P L I Y C R S P D F R I A F
- Q T C H V S P E L Y S A T T W L G Y V N S A L N P V I Y T T F N I E F R K A
- - K N C C N E H L H M F T IW L G Y I N S T L N P L I Y P L C N E N F K K T
- - A P C I P N T V W T I G Y W L C Y I N S T I N P A C Y A L C N A T F K K T
- - A P C I P N T V W T I G Y W L C Y I N S T I N P A C Y A L C N A T F K K T
- - D S C I P K T Y W N L G Y W L C Y I N S T V N P V C Y A L C N K T F R T T
- D A C W F H L A I F D F F T W L G Y L N S L I N P I I Y T M S N E D F K Q A
S C N Q T T LQ M L L E I F V W I G Y V S S G V N P L V Y T L F N K T F R D A
- D C S H A P LW L M Y L A I V L S H T N S V V N P F I Y A Y R I R E F R Q T
- D C S H A P LW L M Y L A I V L S H T N S V V N P F I Y A Y R I R E F R Q T
- V K T C D I L F R A E Y F L V L A V L N S G T N P I I Y T L T N K E M R R A
T F L F D F Y H Y F Y M L T N A L A Y A S S A I N P I L Y N L V S A N F R Q V
C E F E N T V H K W I S I T E A L A F F H C C L N P I L Y A F L G A K F K T S
C S S S N R L D Q A M Q V T E T L G M T H C C I N P I I Y A F V G E E F R N Y
T S H S T A A L S S Y Y F C I A L G Y T N S S L N P I L Y A F L D E N F K R C
I P E T T FQ T V SW H F C I A L G Y T N S C L N P V L Y A F L D E N F K R C
Q P S S E T A V A I L R F C T A L G Y V N S C L N P I L Y A F L D E N F K A C
N R R D P L V V A A L H L C I A L G Y A N S S L N P V L Y A F L D E N F K R C
T S T T E A A Y F A Y L L C V C V S S I S C C I D P L I Y Y Y A S S E C Q R Y
C T A E N T L F Y V K E S T LW L T S L N A C L N P F I Y F F L C K S F R N S
- - - - V S R V V F I Y F N A F L E S FQ G F F V S V F A C F L N S E V R S A
- - - G T L R S A K L F F D L F L S S FQ G L L V A V L Y C F L N K E V Q S E
- - - - - - S N Y K I I T T C F A V S L S V T V A L G C M F T P K M Y I I I A
- - - - - - S N Y K I I T M C F S V S L S A T V A L G C M F V P K V Y I I L A
E I K N R P S L L V E K I N L F A M F G T G I A M S T W V W T K A T L L IW R
30 35 40 45 50 55 60
+ + A S C + P L+ + Y + L T IW L G Y T N S+ L N P + I Y A F L N + E F R R A
Figure C.7: TM 7 alignment for the crystal structures.
86
Appendix D
Sequence Alignment for All Known
GPCRs
We present the alignment of all 817 human GPCR proteins, as worked out in Section 2.4 and Chapter
3. For each TM 1 though 7, the listed residues are residues with Ballesteros-Weinstein number 50.
The numbers in parenthesis denote the expected range of the helical TM regions, which is estimated
as the average TM region in the known crystal structures from the same class.
The following 11 proteins are likely GPCR proteins, but are not present in our alignment because
their sequence similarity to known structures is too low for an unambiguous alignment (listed as
Uniprot IDs):
P51810, Q5T9L3, Q5VW38, O60478, Q86V85, Q86W33, Q8N3F9, Q8NBN3, Q96K49,
Q96N19, Q9NPR9.
The following 8 sequences sometimes get classifies as GPCR proteins, but they are most likely
pseudogenes, because they miss one or more transmembrane regions (listed as Uniprot UDs):
A6NFC9, Q32VQ0, Q8NGA4, Q8NGU1, Q8NGY7, Q8TDU5, Q96P88, Q99463.
In section 3.4 we identified two possible alignments of TM6, but only the first one is presented




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Invoking QEQ in Lammps
E.1 Installing PQEQ Package
We implemented the QEQ and PQEQ methods (described in Chapter 6) in package USER PQEQ
for the general purpose molecular dynamics code LAMMPS [111]. The current PQEQ distribution
is built on LAMMPS version 4Sep13. The package is not yet fully integrated into Lammps and













cp -r USER-PQEQ lammps-4Sep13/src
cd lammps-4Sep13/src










E.2 Implementing Time Integration in LAMMPS
PQEQ implementation consists of two parts: computing the virtual forces on the charges (in the file
pair coul pqeqgauss.cpp), and numerically integrating the equation of motion (fix pqeq.cpp). The
time integration is very similar to the simple NVE time integration implemented in fix nve.cpp. The
appropriate hooks get invoked at the following points in the timestep:
• INITIAL INTEGRATE
• FINAL INTEGRATE
• INITIAL INTEGRATE RESPA
• FINAL INTEGRATE RESPA
We need to add damping and charge conservation. Damping adds hooks at (similar to fix viscous.cpp
but MIN POST FORCE is not used):
• POST FORCE
• POST FORCE RESPA
Charge conservation adds hooks at (like fix shake.cpp but PRE NEIGHBOR is not needed):
• POST FORCE
• POST FORCE RESPA
Note: Instead of relying on setting the total force on the charges to zero, one might consider explicitly
enforcing the total charge to stay exactly 0 (or an integer), which would be done with a hook at
INITIAL INTEGRATE (as in fix recenter.cpp).
E.3 Invoking PQEQ in LAMMPS
PQEQ can be invoked by adding these commands to the Lammps input file:
units real
atom_style pqeq
pair_style coul/pqeqgauss R_cut_inner R_cut_outer
fix pqeq all pqeq damping_time damping_ratio
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A sample input file reads:




pair_style coul/pqeqgauss 10 12
read_data twoatom.data
fix 1 all pqeq 20.0 1.0
thermo 1
dump 1 all custom 1 dump.out id x y z q
timestep 1
run 100
Note that minimization is not implemented for PQEQ.
E.3.1 Data File
The PQEQ parameters are read from the data file. The Atom lines have data in the following order:
id type charge x y z Rsx Rsy Rsz
If hybrid atom style is used, the order or data specific to PQEQ is:
charge Rsx Rsy Rsz
The Pair Coeffs lines have data in the following order:
id chi idem Rcore polar Qcore Rshell K2 K4
The current implementation allows both polarizable and nonpolarizable atoms in the same run.
If polar==0, then only id chi idem Rcore are used; the atom property q is the total charge on
the atom, and Rcore is used as the width of the Gaussian charge. If polar==1, then all parameters
are used and the total charge on the atom is q +Qcore.
Note that the parameters have to be converted to the units consistent with units real. When
units real is used in Lammps the unit of energy is kcal/mol and so the parameters χ =chi,




is cES = 332.06371, when the unit of energy is kcal/mol, unit of distance is A, and unit of charge is
|e|.
The order of parameters on the Atoms line depends on the selected atom style:
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pqeq: id type q coord(3x) rsxs(3x)
pqeq-hybrid: q rsx(3x)
full: id molecule type q coord(3x)
full-hybrid: molecule q
hybrid: id type coord(3x) substyles
E.g. for:
atom_style hybrid full pqeq
The following order of inputs should be entered in the data file:
id type coord(3x) molecule q q rsx(3x)
E.3.2 Caveat for Reading PQEQ Parameters
Values for off-diagonal coefficients are ignored since the QEQ formalism is diagonal in the atom
types. However, when hybrid pair style is used, the coefficients must be explicitly specified in the
input file, so that the interaction is included.
Warning: there is only one flag for a hybrid atom pair style to mark whether the parameters
are diagonal or not, so the usual LAMMPS checks do not work, and one has to manually set all
coefficients for all pair styles used.
AMBER and CHARMM forcefields use arithmetic mixing rule for the Van der Waals parameters,
so with pair styles lj/charmm/coul/charmm and lj/cut typically pair modify one has to use
mix arithmetic. If one used hybrid atom style (which does not allow mixing), one has to specify




σ = 0.5 ∗ (σ1 + σ2) (E.2)
E.4 Usage with ReaxC Implementation
Coulomb energy included in the ReaxC code has to be turned off, and Coulomb energy from PQEQ
is used instead. This is done with a keyword coulomb off yes and has to be accompanied with
checkqeq no, since the QEQ from ReaxC is not used. For example:
pair_style reax/c control_file coulomb_off yes checkqeq no
The current implementation of the coulomb off option might not be the most efficient. We simply
commented out the computation of Coulomb interactions in the ReaxC code.
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E.5 Usage with Force Fields in Lammps
Force fields do not include Coulomb force for bonded atoms (1-2 and 1-3 interactions) and 1-4
interactions are often accounted for partially. In LAMMPS this behavior is controlled by the variable
special bonds. We want to keep this behavior for computing physical forces on atoms, but we need
to include our modified Coulomb interaction into the computation for the auxiliary forces FQ and
FRS . For QEQ there is no issue. For PQEQ, it should be checked that this asymmetrical handling of
forces (action 6= reaction) is fine. The quantity counted into the total energy is the one corresponding
to the real forces.
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